Stockwinners Market Radar for May 21, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
GOLD | Hot Stocks19:18 EDT Barrick says Acacia proposal reflects 'fair value' following Tanzania talks - Barrick Gold Corporation provided an update in relation to Acacia. Barrick met today with the Directors and senior management of Acacia and presented a proposal to acquire all of the shares it does not already own in Acacia through a share for share exchange of 0.153 Barrick shares for each ordinary share of Acacia. The Proposal assumes that no further dividends will be paid by Acacia following the date of the Proposal. The exchange ratio is based on the 20-day volume weighted average trading prices of Acacia and Barrick as at market close in London and New York on 20 May 2019. This implies a value for Acacia of $787M and total consideration to the minority shareholders of Acacia of $285M. Barrick has been negotiating with the Government of Tanzania for the last two years to seek a basis for a settlement of Acacia's ongoing disputes with the GoT and to establish a viable framework under which Acacia could resume its full operations in Tanzania and rebuild its relationships with the GoT. While a basis for a settlement has been developed but not finalized, in meetings this past weekend, the GoT stated that it is not prepared to enter into a settlement directly with Acacia. As a consequence of the negotiations with the GoT, Barrick has had the opportunity to undertake detailed due diligence on the Acacia assets and on the basis of this work has concluded that the Proposal reflects the fair value of the company. Since the Proposal is in Barrick shares, the Acacia minority shareholders will be able to benefit from any future potential upside in both the Acacia assets and Barrick's broader portfolio of assets.
|
SE | Hot Stocks19:04 EDT Sea Limited reports Q1 QAUs up 114.4% from last year - Reports Q1 Quarterly active users, or QAUs, reached 271.6M, up 114.4% from last year. Q1 average revenue per user rose to $1.40 from $1.20 last year.
|
OOMA... | Hot Stocks18:47 EDT Fly Intel: After Hours Movers - UP AFTER EARNINGS: Ooma (OOMA) up 1.4%. ALSO HIGHER: CVR Energy (CVI) up 3.7% after announcing review of strategic alternatives... PVH Corp (PVH) up 3.2% after naming former Ralph Lauren CEO as president. DOWN AFTER EARNINGS: Pure Storage (PSTG) down 19.1%... Nordstrom (JWN) down 9.1%... Urban Outfitters (URBN) down 5.6%... Toll Brothers (TOL) down 3.3%. ALSO LOWER: OncoSec Medical (ONCS) down 27.5% after equity offering... Ekso Bionics (EKSO) down 24.7% after equity offering... Tocagen (TOCA) down 21.0% after disclosing modification to its Phase 3 trial evaluating Toca 511 & Toca FC in glioma patients... LiqTech International (LIQT) down 13.5% after equity offering. Movers as of 18:30ET.
|
TREX | Hot Stocks18:45 EDT Trex Company CEO: There is no demand issue - In an interview on CNBC's Mad Money, Trex Company CEO James Cline said: We had a tough start to a new product introduction... There is no demand issue... There is actually more demand than we anticipated... We are 95% recycled material... Environmental consciousness is important to us and it's a money saver.
|
JCOM | Hot Stocks18:25 EDT j2 Global CFO sells 5.6K shares of common stock - In a regulatory filing, j2 Global disclosed that its CFO Scott Turicchi sold 5.6K shares of common stock on May 17th and May 20th. The total transaction size was just under $490K.
|
NVS | Hot Stocks18:24 EDT Novartis CEO: We are entering an exciting growth phase for the company - In an interview on CNBC's Mad Money, Novartis CEO Vasant Narasimhan said: We are moving to a world where we could have one-time curative therapies... We need a system that allows payments over time... We should fix some of the distortions in the current system... We should look at more biosimilars in the U.S... We have string of blockbuster launches this year... We are a diversified medicines company... The lifeblood of the industry is high-end innovation.
|
GOOG GOOGL | Hot Stocks18:01 EDT Google updates policy on abortion-related ads - Google said in a post that in June 2019, the Google Ads healthcare and medicines policy for abortion will be updated with the following requirements for advertisers in the United States, United Kingdom, and Ireland: Advertisers who want to run ads using keywords related to getting an abortion will first need to be certified as an advertiser that either provides abortions or does not provide abortions; To get certified, advertisers must submit an application where they self-declare as an organization that either provides abortions or does not provide abortions. The application will require some basic information about your organization. Once your submitted information has been reviewed and verified, you'll receive a certification; Depending on how you're certified Google will automatically generate one of the following in-ad disclosures for your abortion product or service ads: "Provides abortions" or "Does not provide abortions"; The disclosures will show on all Search ad formats. This added transparency will help ensure that users have the necessary information to decide which abortion-related ads are most relevant to them. While this policy won't go into effect until June 2019, advertisers can apply for certification beginning today. Reference Link
|
HAIN | Hot Stocks17:50 EDT Engaged Capital raises stake in Hain Celestial to 20.2% from 18.3% - Engaged Capital raised its stake to 20.2%, representing 21,071,229 shares, from an 18.3% stake reported on May 15. This stake, reported in a 13D, filing allows for activism.
|
NTDOY | Hot Stocks17:48 EDT Nintendo to end 'Animal Crossing,' 'Fire Emblem' mobile game service in Belgium - Nintendo announced that, due to the "current unclear situation" in Belgium regarding certain in-game revenue models, it has decided to end service of mobile titles "Animal Crossing: Pocket Camp" and "Fire Emblem Heroes" in Belgium. It will therefore no longer be possible to play and download the games from August 27, 2019. In addition, future Nintendo games with similar earnings models will no longer be released in Belgium, the company said. Reference Link
|
URBN | Hot Stocks17:44 EDT Urban Outfitters sees Q2 URBN retail SSS in low single-digit negative range - Says guidance based on QTD performance. Says if comp sales do come in low single-digit negative, it believes gross margin rates for Q2 could deleverage by more than 300 basis points. Says decrease in gross profit margin could be due to higher markdown rates to clear underperforming products as well as deleverage and delivery logistics. Sees Q2 SG&A growth roughly 2%. Sees FY19 CapEx roughly $260M. Comments taken from Q1 earnings conference call.
|
GLD | Hot Stocks17:42 EDT SPDR Gold Shares holdings rise to 739.69MT from 736.17MT - This is the highest level of holdings since May 9th.
|
ASCMA | Hot Stocks17:38 EDT Ascent Capital and Monitronics International announce restructuring support pact - Ascent Capital Group announced that its wholly owned subsidiary Monitronics International has entered into a Restructuring Support Agreement with its largest creditors that will eliminate approximately $885M in debt. Under the terms of the Support Agreement, up to approximately $685M of debt will be converted to equity, including up to approximately $585M of the company's 9.125% Senior Notes due in 2020 and $100M of the company's term loans. The company will also receive an additional $200M in cash from the company's noteholders through an equity rights offering and, subject to certain conditions, from Ascent in connection with the proposed merger with Monitronics which cash will be used to, among other things, repay remaining term loan debt. Following the completion of the restructuring, the Company is currently expected to have approximately $990M of total debt. Recurring Monthly Revenue as of March 31, 2019, was $40.8M. Under the terms of the Support Agreement, Monitronics and its subsidiaries would effectuate the proposed transactions through a partial pre-packaged plan of reorganization under Chapter 11 of the U.S. Bankruptcy Code. The Company has already obtained support for the proposed transactions from holders of approximately 83 percent of its secured term loans and approximately 72% of its senior unsecured notes.
|
TRS | Hot Stocks17:33 EDT TriMas VP Joshua Sherbin sells over $646K in company shares - TriMas VP Joshua Sherbin disclosed in a filing that he has sold 21,355 shares of company stock at $30.26 per share between May 19 and May 20. The total transaction value of the sale was $646,172.
|
GVA | Hot Stocks17:31 EDT Granite Construction awarded $505M high speed rail contract - Granite announced it has been awarded a $505M higher-speed rail project by Virgin Trains USA Florida for their expansion to Orlando, Florida. Of the total contract value, approximately $490M was booked in Granite's Q4 2018 backlog and the remaining $15M will be included in its Q2 2019 backlog. Construction is anticipated to begin in summer 2019 and is estimated to be complete by 2022.
|
TTEC | Hot Stocks17:26 EDT TTEC Holdings EVP DeGhetto sells 35K shares of common stock - In a regulatory filing, TTEC Holdings disclosed that its EVP Martin DeGhetto sold 35K shares of common stock on May 17th and May 21st. The total transaction size was $1.37M.
|
TDW | Hot Stocks17:25 EDT Tidewater director Dick Fagerstal purchases almost $107K shares of company stock - Tidewater director Dick Fagerstal disclosed in a regulatory filing that he had purchased 4,400 shares of company stock at an average price of $24.30 per share on May 20. The total transaction value of the purchase was $106,921.
|
PTCT | Hot Stocks17:16 EDT Point72 Asset Management takes 5.0% passive stake in PTC Therapeutics - Point72 Asset Management disclosed a 5.0% stake in PTC Therapeutics, which represents over 2.93M shares. The filing does not allow for activism.
|
PVH RL | Hot Stocks17:09 EDT PVH Corp. appoints former Ralph Lauren CEO Stefan Larsson to president - PVH Corp. announced the appointment of Stefan Larsson to the newly created role of President, PVH Corp. effective June 3. Larsson will have the responsibility for managing PVH's branded businesses and regions, with each of the three brand CEOs and the Regional Presidents reporting to him. He will report to Emanuel Chirico, PVH's Chairman and CEO. In connection with this announcement, Mr. Chirico signed a new five-year employment agreement with the company. PVH Presiding Director, Henry Nasella commented that "With the signing of Manny's new employment agreement and the hiring of Stefan in the newly created role of President, we believe that PVH is extremely well-positioned from a leadership and a management succession perspective to continue to execute our strategic plans well into the future." Larsson was most recently CEO of Ralph Lauren (RL), where he successfully refocused the company on what made it iconic, improved its performance and set the path for future growth.
|
RICK | Hot Stocks17:07 EDT RCI Hospitality receives Nasdaq noncompliance notice - RCI Hospitality Holdings, Inc. has received, as anticipated, a letter from the Listing Qualifications Department of the Nasdaq Stock Market notifying the company of its noncompliance with Listing Rule 5250c1, which requires the timely filing of reports with the SEC. Nasdaq's May 17, 2019 letter was sent as RCI has not yet filed its Form 10-Q for the quarter ended March 31, 2019. RCI intends to regain compliance and file its 10-Q as soon as practicable. Nasdaq's letter has no immediate effect on the listing of RCI common stock on the Nasdaq Stock Market. Under Nasdaq's rules, the company has until July 16, 2019 to file its 10-Q or submit a plan to regain compliance with continued listing requirements. If Nasdaq accepts the plan, it may grant an exception of up to 180 calendar days from the 10-Q's due date, or up to November 6, 2019, to regain compliance. RCI may regain compliance at any time during the 180-day period upon filing its 10-Q as well as all subsequent required periodic financial reports due within that period. If Nasdaq does not accept the company's plan, RCI will have the opportunity to appeal that decision to a Nasdaq panel.
|
LPLA | Hot Stocks17:03 EDT LPL Financial to acquire Allen & Company - LPL Financial announced LPL has entered into a definitive purchase agreement to acquire Allen & Company of Florida, a broker/dealer and registered investment adviser based in Lakeland, Florida. Allen & Company employs approximately 30 advisors and serves approximately $3B of client assets. The purchase agreement was signed on May 17 and the transaction is anticipated to close by the end of the year, subject to receipt of regulatory approval and other customary closing conditions. Under the transaction structure, LPL will onboard Allen & Company advisors and staff as employees and maintain Allen & Company's operations and brand. Allen & Company client assets will onboard with LPL's custodial platform. The purchase agreement provides for an initial purchase price and a potential contingent payment based on the portion of Allen & Company's client assets that are onboarded to LPL's platform above a specified threshold. The company estimates a transaction multiple of seven times post-synergy EBITDA.
|
CVI | Hot Stocks16:46 EDT CVR Energy to evaluate strategic alternatives, including 'potential sale' - CVR Energy announced that it has engaged BofA Merrill Lynch as its financial advisor to assist it in evaluating potential strategic alternatives, including a potential sale. CVR Energy also announced that its subsidiary has entered into a definitive agreement for the sale of its 1.5M-barrel Cushing, Oklahoma, crude oil terminal and related assets to an affiliate of Plains All American Pipeline, L.P. for total consideration of approximately $36B, and concurrently closed the transaction. CVR Energy does not have a defined timeline for the exploration of strategic alternatives and makes no assurances that its evaluation will result in any transaction being announced or consummated.
|
SFIX | Hot Stocks16:46 EDT Park West Asset Management reports 5% passive stake in Stitch Fix - In a regulatory filing, Park West Asset Management disclosed a 5% stake in Stitch Fix, which represents 2.23M shares. The filing does not allow for activism.
|
PTVCA AIG | Hot Stocks16:45 EDT Protective Insurance appoints Jeremy Johnson as CEO - Protective Insurance (PTVCA)announced that its Board of Directors has appointed Jeremy D. Johnson as CEO, effective tomorrow; Johnson will also serve as a member of the Company's Board of Directors. Johnson most recently served as President, US Commercial for American International Group (AIG), from February 2016 to December 2017, with responsibility for underwriting, operations, claims and distribution in the US, Canada, Brazil, Mexico and Puerto Rico. He served as CEO and President of Lexington Insurance Company, AIG's excess and surplus lines unit, from February 2013 to December 2017. Johnson served in various executive leadership roles at AIG between 2000 and 2013, including Specialty Product Line Executive, U.S. & Canada; President of Cat Excess Liability; U.S. Executive for Energy Excess Casualty; and Regional Vice President for the Mid-Atlantic territory. Prior to joining AIG, Johnson was a broker for Sedgwick, and Marsh.
|
TOL | Hot Stocks16:43 EDT Toll Brothers reports Q2 home sales gross margin 23.5% vs.22.5% last year - Sees Q3 home sales gross margin around 22.5% and FY19 home sales gross margin around 23.0%.
|
TDS | Hot Stocks16:43 EDT Telephone and Data VP Joseph Hanley sells almost $499K in company shares - Telephone and Data VP Joseph Hanley disclosed in a filing that he had sold 15,867 shares of company stock at an average price of $31.42 per share on May 20. The total transaction value of the sale was $498,541.
|
PKOH | Hot Stocks16:41 EDT Park-Ohio reaches agreement in principle to acquire Erie Press Systems - ParkOhio announced that it has reached an agreement in principal to acquire EFCO, Inc. d/b/a Erie Press Systems, headquartered in Erie, Pennsylvania. Erie Press is an industry recognized leader in the manufacturing of advanced forging presses, hydraulic and mechanical presses, and metal stretch-forming and carbon extrusion machines for several end markets, including aerospace and defense, primary metals and high-speed rail. The deal is subject to a definitive agreement with customary closing conditions. The transaction is expected to close in the second quarter.
|
TOL | Hot Stocks16:41 EDT Toll Brothers CFO sees 'slower demand and rising incentives' in Q3 - CFO Martin Connor says: "In our second quarter, we delivered strong home building revenues and profit margins. Our guidance for adjusted home sales gross margin during the balance of the year reflects the slower demand and rising incentives associated with the challenging sales environment of the fall and winter as well as changes in mix.
|
AL EADSY | Hot Stocks16:35 EDT Air Lease announces delivery of New Airbus A350-900 aircraft to Sichuan Airlines - Air Lease Corporation (AL) announced the delivery of one new Airbus (EADSY) A350-900 aircraft on long-term lease to Sichuan Airlines. Featuring Trent XWB-84 engines, this A350-900 is the first ALC A350-900 to deliver to an airline in China.The aircraft is from ALC's order book with Airbus and joins eight Airbus aircraft currently on lease from ALC to Sichuan Airlines for a total of nine aircraft. "Sichuan Airlines is a loyal long-term customer of ALC and we are pleased to be leasing our new A350-900 to the airline," said Steven F. Udvar-Hazy, Executive Chairman of Air Lease Corporation. "This significant delivery further strengthens our close relationship and we are confident this new widebody aircraft will complement the airline's current fleet operations, adding technological and innovative advancements that will bring a whole new experience to Sichuan's offerings." "We are very pleased to announce this new A350-900 delivery to our distinguished customer, Sichuan Airlines," said Jie Chen, Air Lease Corporation's Executive Vice President and Managing Director, Asia. "ALC is proud to introduce the airline to the A350-900 and pioneer modernizing the airline's long-haul fleet to maximize Sichuan Airlines' fleet operations and global growth."
|
TOL | Hot Stocks16:35 EDT Toll Brothers sees Q3 deliveries 1.8K-2.0K units with avg price $855K-$880K - Sees FY19 deliveries 7.7K-8.1K with an average price of between $855K-$880K.
|
FLNT | Hot Stocks16:33 EDT Fluent promotes Tamara Alesi to CGO - Fluent announced the promotion of Tamara Alesi to chief growth officer, or CGO, effective immediately. As CGO, Alesi will play a key role in overall business innovation, media and operations, including new product development and strategy. She will also serve as a key thought leader and partner to the CEO and executive leadership team. A marketing and media industry veteran with over 20 years of experience, Alesi joined Fluent earlier this year as senior VP of media strategy. Prior to Fluent as an agency executive, she built and managed several global brands.
|
TOL | Hot Stocks16:33 EDT Toll Brothers reports Q2 home building deliveries 1.9K, up 1% - Reports Q2: Net signed contract value was $2.0B, down 16%; Contract units 2,424, down 9%; Backlog value $5.66B, down 11%; Units in backlog 6,467, down 8%.
|
ESRT | Hot Stocks16:33 EDT Empire State Realty CFO David Karp steps down, Andrew Prentice named acting CFO - Empire State Realty Trust announced that David Karp will be stepping down from his role as Executive Vice President and CFO for personal reasons, effective August 1. In accordance with the company's bylaws, Andrew Prentice, Chief Accounting Officer and Treasurer, will serve as acting CFO while the company conducts a search for a permanent successor. John Kessler, President and COO, will lead the team during the transition.
|
KHC | Hot Stocks16:33 EDT Kraft Heinz still not in compliance with Nasdaq listing rule - The Kraft Heinz announced that on May 17 as expected, Kraft Heinz received a standard notice from Nasdaq stating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for the quarter ended March 30, Kraft Heinz continues to not be in compliance with Nasdaq Listing Rule 5250, which requires timely filing of periodic financial reports with the SEC. Kraft Heinz previously received an initial notice on March 15 related to the delay in timely filing its Annual Report on Form 10-K for the FY18. Previously, Kraft Heinz timely submitted a plan to regain compliance to Nasdaq and in the notice received on May 17 Nasdaq also notified Kraft Heinz that it had been granted until September 11 to regain compliance with Nasdaq Listing Rule 5250 by filing the Form 10-K and Form 10-Q and complying with certain other terms outlined in the notice. Kraft Heinz currently expects to cooperate with Nasdaq to comply with such terms.
|
MYL | Hot Stocks16:30 EDT FDA: Mylan broadens recall of Valsartan tablets - Mylan N.V.External Link Disclaimer announced that its U.S. based Mylan Pharmaceuticals business is expanding its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within expiry. The 104 additional lots include 26 lots of Amlodipine and Valsartan Tablets. Reference Link
|
IT | Hot Stocks16:25 EDT Gartner VP Robin Kranich sellls over $980K in company shares - Gartner VP Robin Kranich disclosed in a filing that he had sold 6,366 shares of company stock at $154.27 per share on May 17. The total transaction value of the sale was $982,086.
|
PSTG | Hot Stocks16:22 EDT Pure Storage down 17% to $17.10 after Q1 results miss estimates - The company's Q2 and FY20 revenue guidance, at the midpoint, also fell short of estimates.
|
EXPR | Hot Stocks16:21 EDT Express appoints Timothy Baxter CEO - Express announced that the company's board has appointed Timothy Baxter CEO, effective June 17. He will assume day-to-day leadership of the company and will also join Express' board. Baxter was most recently CEO of Delta Galil Premium Brands. Baxter will succeed Matthew Moellering, who has served as interim president and interim CEO since January. Moellering will remain with Express as executive VP and COO.
|
TRNS | Hot Stocks16:17 EDT Transcat sees FY20 CapEx $7.8M-$9.2M - Transcat expects its income tax rate to range between 22% and 23% in fiscal 2020. This estimate includes Federal, various state, and Canadian income taxes and reflects the increased discrete tax accounting windfall associated with share-based payment awards. In particular, this impact is expected to result in a significantly lower first quarter fiscal 2020 tax rate of between 10% and 11%. The company anticipates total capital expenditures to be approximately $7.8M-$8.2M in fiscal 2020, with the majority of the incremental capital expenditures in excess of fiscal 2019 spend levels planned for growth-oriented opportunities within both of its operating segments. Maintenance/existing asset replacements are expected to be consistent with fiscal 2019 at approximately $1M-$1.5M.
|
AYR | Hot Stocks16:17 EDT Aircastle raises repurchase program up to $100M from $76M - Aircastle announced that the Company's Board of Directors increased the authorization to repurchase up to $100M of the Company's common shares, from the $76M that was remaining under the existing authorization. Since 2011, the Company has repurchased 18.5M shares at an average cost of $14.57 per share. Under the program, the Company may purchase its common shares from time to time in the open market or in privately negotiated transactions. The amount and timing of the purchases will depend on a number of factors, including the price and availability of the Company's common shares, trading volume and general market conditions. The Company also announced the election by shareholders of Jun Horie to the Board and the appointment of Takashi Kurihara to the Board. Horie is the President and CEO of Marubeni America and replaces Hajime Kawamura, who did not stand for reelection. Kurihara, Advisor to the President of Marubeni America, was appointed to replace Gentaro Toya, who resigned from the Board.
|
RDNT | Hot Stocks16:16 EDT RadNet officer John Crues sells 20K shares of company stock - RadNet officer John Crues disclosed in a filing that he had sold 20,000 shares of company stock at $13.15 per share on May 16. for a total transaction value of $263,000.
|
PRSP | Hot Stocks16:16 EDT Perspecta increases quarterly dividend 20% - Perspecta announced that its board approved an increase in the company's regular cash dividend approach for FY20, declaring a cash dividend of 6c per share for the quarter ended March 31, a 20% increase over the previous quarterly cash dividend of 5c per share. The dividend is payable July 16 to shareholders of record at the close of business on June 5. Payment of quarterly dividends is subject to authorization by Perspecta's board.
|
LUV | Hot Stocks16:15 EDT Southwest says new AMFA contract 'benefits all parties' - Southwest Airlines announced the company's Mechanics and Related Employees, represented by the Aircraft Mechanics Fraternal Association, have voted to ratify a new tentative agreement. "Our Mechanics will receive well-deserved pay increases, and the Company will realize additional flexibilities necessary to compete in today's airline industry," said Vice President of Labor Relations Russell McCrady. "This new contract benefits all parties as it takes care of our People and preserves the long-term health of Southwest Airlines." Southwest's 2,400 Mechanics and Related Employees will immediately be covered by the ratified contract, which will become amendable in April 2024, the company said.
|
PSTG | Hot Stocks16:12 EDT Pure Storage down 15% to $17.36 after Q1 results miss estimates
|
JWN | Hot Stocks16:12 EDT Nordstrom falls over 9% to $34.15 after Q1 earnings miss, cut in FY19 guidance
|
NBY | Hot Stocks16:11 EDT NovaBay receives NYSE American noncompliance communication - NovaBay Pharmaceuticals announced that on May 16, 2019 it received notice from the NYSE American LLC that it is not in compliance with Sections 1003ai and 1003aii of the NYSE American Company Guide requiring stockholders' equity of $2M or more and $4M or more, respectively, if the company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years. According to the Exchange, this notice does not impact the company's ongoing plan to regain compliance with continued listing standards, which requires the company to regain such compliance by October 12, 2020 or be subject to delisting procedures. On May 11, 2019, the company submitted its plan to regain compliance to the Exchange, which is pending approval by the Exchange. If the NYSE American accepts the plan, the common stock will continue to be listed and traded on the NYSE American during that specified period. If the company does not regain compliance with NYSE American listing standards, or does not make progress consistent with the plan, the NYSE American staff may commence delisting proceedings.
|
BC | Hot Stocks16:10 EDT Brunswick closes acquisition of Freedom Boat Club - Brunswick Corporation announced it has completed its previously announced acquisition of Freedom Boat Club. Terms of the transaction were not disclosed.
|
IMMR | Hot Stocks16:10 EDT Immersion signs license agreement with Panasonic Avionics for in-flight systems - Immersion (IMMR) announced it has signed a license agreement with Panasonic (PCRFY) Avionics Corporation. The agreement provides Panasonic Avionics with access to Immersion's patented haptic technology for use in in-flight entertainment systems.
|
SNOA | Hot Stocks16:09 EDT Sonoma sells animal health product rights in Asia, Europe - Sonoma Pharmaceuticals announced the sale of certain animal health product rights and assets for the Asian and European markets to Petagon, Limited, an international importer and distributor of quality pet food and products, for $2.7M. Petagon has been a distributor of Microcyn AH products in the Chinese, Hong Kong and other Asian markets for the past five years. The sale involves certain Asian patents and trademarks and the exclusive right to distribute animal health care products in Asia and Europe. Petagon will continue to source animal health products from Sonoma for a period of at least five years.
|
QGEN | Hot Stocks16:09 EDT Qiagen's QuantiFERON-TB program gains recognition from UN health initiative - Qiagen announced that QuantiFERON-TB Access, a new solution under development for diagnosis of latent tuberculosis infection in low-resource regions with a high disease burden of tuberculosis, will be recognized by the Joint United Nations Programme on HIV/AIDS at the organization's Health Innovation Exchange from May 21-23 in Geneva, Switzerland. The event will be held during the World Health Assembly and brings together ministers of health, nonprofits and industry to spotlight innovations with potential to change the world's health landscape and benefit sustainable development. QuantiFERON-TB Access is a proprietary new test designed to advance tuberculosis control in areas with limited infrastructure, including countries in Asia, Africa and Latin America. The World Health Organization has classified 30 countries in these regions as high-burden, representing an estimated 85% of the global TB burden. QFT Access pairs highly sensitive digital detection with a complete workflow created to deliver cost-efficient results quickly and with unmatched simplicity. It eliminates the need for an extensive laboratory infrastructure while providing best-in-class QuantiFERON technology. Clinical trials are being conducted in 2019, and commercialization of QFT Access is expected to begin in 2020. "We are pleased that UNAIDS selected QuantiFERON-TB Access for recognition at the Health Innovation Exchange. QIAGEN's drive to develop QFT Access springs from the need for a modern, accurate test for TB infection screening in areas where the disease burden is high but resources and infrastructure are scarce," said Thierry Bernard, Senior Vice President, Head of the Molecular Diagnostics Business Area at QIAGEN. "QFT Access builds on the success of QuantiFERON-TB Gold Plus, the modern gold standard for detection of latent TB infection. We have created a field-friendly Sample to Insight solution using a simple test to reduce costs and labor and avoid the need for cold chain, a computer or continuous power supply."
|
RCKY | Hot Stocks16:08 EDT Rocky Brands raises quarterly dividend 16.7% to 14c per share - Rocky Brands announced that its board of directors has approved a 2c increase, or a 16.7% increase, of its quarterly dividend to 14c per share of outstanding common stock, which will be paid on June 17, 2019 to all shareholders of record as of the close of business on June 3, 2019.
|
URBN | Hot Stocks16:08 EDT Urban Outfitters launches Nuuly women's apparel subscription rental service - Urban Outfitters announced the launch of Nuuly, a women's apparel, subscription rental service with a Summer 2019 launch. Nuuly is a "new way to experience clothing-a monthly subscription service with a robust offering of URBN's own brands, third-party labels and one-of-a-kind vintage pieces for rent via a custom-built, digital platform." Subscriptions will cost $88 for one, 6-item box per month, offering subscribers on average over $800 worth of initial retail value per box.
|
JWN | Hot Stocks16:07 EDT Nordstrom reports Q1 net sales down 3.5% - Co-President Erik Nordstrom says: "While we expected softer trends from the fourth quarter to continue into the first quarter, we experienced a further deceleration. We had executional misses with our customers, and we're committed to better serving them. This is well within our control to turn around... The strength of our inventory and expense execution helped mitigate a meaningful portion of our sales miss. We ended the quarter with inventories in solid shape, and our financial position remains strong. We're actively taking steps to drive our top-line, and we're focused on delivering on our financial goals."
|
HXL | Hot Stocks16:07 EDT Hexcel sees total sales CAGR 6%-9% from 2019-2021 - Chairman, CEO and President Nick Stanage said: "We expect strong sales growth over the next three years and beyond, with adjusted diluted earnings per share to grow at a double-digit rate, supported by Operational Excellence. We expect continued expansion of free cash flow generation, providing a total of $1.8 billion between 2019 and 2023 which will be available for continued investment in organic growth, for strategic acquisitions, and to return to shareholders." Sees adjusted EPS to grow at double digit CAGR from 2019-2021. Sees CapEx of $500M-$550M during three year period.
|
TOCA | Hot Stocks16:07 EDT Tocagen's Toca 5 Phase 3 clinical trial continues with modification - Tocagen announced the Toca 5 Phase 3 clinical trial evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma, or HGG, continues without modification following a planned interim analysis of data conducted by an Independent Data Monitoring Committee, or IDMC. The IDMC completed its analysis and recommended the trial continue without modification. The global trial enrolled patients across two periods of time and completed full enrollment of 403 patients in November 2018. The Toca 5 trial is one of the largest randomized trials conducted in patients with recurrent high grade glioma. The international trial is a Phase 3 multi-center trial evaluating the safety and efficacy of Toca 511 & Toca FC compared to standard of care in patients undergoing resection for recurrent high grade glioma.
|
PSTG | Hot Stocks16:06 EDT Pure Storage reports Q1 adjusted gross margin 68.1%
|
REZI | Hot Stocks16:05 EDT Resideo acquires energy efficiency technology from Whisker Labs - Resideo Technologies announced it has acquired innovative energy efficiency technology from Whisker Labs and hired the team behind it. The technology creates a thermodynamic model of a home to accurately predict home heating and air conditioning run time and energy use to enable a homeowner to use less energy while maintaining comfort.
|
IRIX | Hot Stocks16:04 EDT IRIDEX appoints David Bruce CEO - IRIDEX Corporation announced the appointment of David Bruce to be the company's president and CEO, effective immediately. Bruce has been a member of IRIDEX's board since April, 2018 and has held several CEO and leadership positions in both public and private medical device growth-stage companies.
|
OBLN | Hot Stocks16:03 EDT Obalon says expanded data set for the Obalon balloon system presented at DDW - Obalon Therapeutics announces that expanded clinical data from the Company's large-scale commercial use study was presented at the Digestive Disease Week, DDW, 2019 Annual Conference, held May 18-21, 2019 in San Diego, CA. The 1,411-patient data presentation titled, Predictors of Weight Loss In Patients Treated With A Swallowable Gas-Filled Intragastric Balloon System For Six Months: Results From A U.S. Registry, continues to demonstrate the real-world utility of the Obalon Balloon System, with weight loss and safety results from 143 treatment sites in the United States.
|
SBGI | Hot Stocks15:50 EDT Sinclair Broadcast's Keith sells 13,250 class A common shares - In a regulatory filing, Sinclair Broadcast director Daniel C. Keith disclosed the sale of 13,250 class A common shares of the company at a price of $56.5786 per share.
|
FCAU | Hot Stocks15:50 EDT Fiat Chrysler says plans to build assembly plant in Detroit approved - "Thanks to the strong support of Governor Whitmer, the Michigan Economic Development Corporation and city of Detroit, I am pleased to confirm that plans to invest in our Jefferson North Assembly Plant and build a new state-of-the-art assembly plant in Detroit have been given the green light. At FCA, we are continuing to build a secure future, not only for our Company but also for the communities in which we operate. This investment enables us to deliver on this promise in the state and city we call home," said Mark Stewart, Chief Operating Officer, FCA - North America.
|
OCX | Hot Stocks15:16 EDT OncoCyte presents 'positive' results from R&D validation study of DetermaVu - OncoCyte presented results from the company's R&D Validation study at the American Thoracic Society 2019 International Conference, which is being held May 17 to May 22 in Dallas. The poster details the compelling results from the company's successful R&D Validation study of DetermaVu, OncoCyte's liquid biopsy test for the early detection of lung cancer. The R&D Validation study demonstrated a sensitivity of 90% and specificity of 75% of DetermaVu on a prospectively collected cohort of 250 patient blood samples that were blinded to laboratory operators. "We are very pleased to present for the first time the strong findings from our R&D Validation study of DetermaVu at this year's ATS meeting. We believe these results are poised to redefine the paradigm in lung cancer detection," said Lyndal Hesterberg, Chief Scientific Officer of OncoCyte. "Most notably, we were able to achieve these results using gene-expression biomarkers alone and without the use of clinical parameters such as nodule size that are solely employed by the Mayo model and other algorithm models currently used to estimate the probability of cancer in patients with pulmonary nodules. Our unique Immune System Interrogation approach can potentially detect lung cancer in earlier stages of the disease when more favorable patient outcomes are feasible. We are excited about the potential of this novel test to positively impact the lives of patients globally, and are rapidly advancing through remaining development studies as we work to make DetermaVu commercially available in the second half of this year."
|
TPL | Hot Stocks15:02 EDT Texas Pacific Land Trust files lawsuit against trustee Eric Oliver - Texas Pacific Land Trust announced that it has filed a lawsuit in the United States District Court for the Northern District of Texas against Eric Oliver for violations of federal securities laws in connection with the proxy contest Oliver initiated to be elected as a trustee of TPL. The Trust also announced that the special meeting of shareholders previously scheduled to be convened on May 22, and to be adjourned until June 6, has been postponed until further notice. "We have repeatedly raised serious questions about Mr. Oliver's background and potential conflicts of interest, to which he has refused to provide an adequate reply. Election of an unqualified or conflicted trustee could cause significant harm to the Trust and its shareholders, so we have no choice but to ask the Court to help us protect shareholders' interests. We have postponed the special meeting to ensure that shareholders have the opportunity to cast a fully informed vote," said trustee David Barry.
|
PM | Hot Stocks14:58 EDT Philip Morris announces creation of new senior management team roles - Philip Morris International announced the company has created the following new roles: Chief Consumer Officer, or CCO; Chief Life Sciences Officer, or CLSO; Chief Product Officer, or CPO; and Chief New Ventures Officer, or CNVO. All four executive positions will report to CEO Andre Calantzopoulos as part of PMI's senior management team. The role of CCO will be filled by Stefano Volpetti, who will be responsible for "grouping all consumer-facing experiences across the consumer journey." The CLSO will be Dr. John O'Mullane, who "will build upon PMI's unique scientific capabilities in RRPs and outline the company's scientific strategy for new products and services." Mirek Zielinski, the current President Science & Innovation, will assume the new role of Chief New Ventures Officer. The CPO role "has been filled by an experienced leader from the electronics industry and will be announced in the forthcoming weeks. The CPO will be accountable for the development and acceleration of the company's innovative smoke-free product pipeline, related technologies and electronic devices manufacturing," the company said.
|
PED | Hot Stocks14:21 EDT PEDEVCO Corp. announces sale of stock to SK Energy, two unaffiliated investors - PEDEVCO Corp. announced that it has raised $15M through the sale of restricted common stock at $2.20 per share to SK Energy, an investment firm owned by Dr. Simon Kukes, the company's CEO, and an additional $3M through the sale of restricted common stock at $2.00 per share to two investors unaffiliated with the company. Combined, the company raised an aggregate of $18M of unrestricted cash through these private offerings at a blended average purchase price per share of $2.16, the proceeds from which the company plans to apply toward funding the company's 2019 Permian Basin asset development program and acquisition activities. Kukes, the company's CEO, commented, ''Given the recent exceptional results from the company's first two horizontal wells put online in the Permian Basin, I am investing an additional $15M at a premium to the company's recent trading price to further fund the company's development of its conventional San Andres assets, which have an estimated 700 million barrels of oil equivalent remaining in place and over 150 potential drilling locations identified by the company."
|
PED | Hot Stocks14:20 EDT PEDEVCO Corp. trading resumes
|
XRX | Hot Stocks14:12 EDT Xerox shareholders approve holding company reorganization - Xerox announced that shareholders approved its proposal to adopt the merger agreement pursuant to which Xerox expects to implement a holding company reorganization. Holders of approximately 99.7% of common shares present and voting at Xerox's annual meeting, representing approximately 77.0% of the company's total outstanding common shares, voted in favor of the proposal. The closing of the holding company reorganization remains subject to the satisfaction of customary conditions, including, receipt of approval from the Financial Conduct Authority of the United Kingdom. Xerox is targeting Q3 of 2019 for the closing of the holding company reorganization. Following the closing, it is expected that the common stock of the holding company will trade on the New York Stock Exchange under Xerox's current trading symbol, "XRX."
|
PED | Hot Stocks13:51 EDT PEDEVCO Corp. trading halted, news pending
|
CIR | Hot Stocks13:47 EDT CIRCOR trading resumes
|
PYDS | Hot Stocks13:46 EDT Payment Data Systems jumps over 7% after announcing pact with Pineapple Payments - Earlier on Tuesday, Payment Data Systems announced that it had entered into a strategic partnership agreement with Pineapple Payments, a leader in omni-channel payment acceptance solutions, combining their leading technology to offer merchants best-in-class payments technology. The Agreement connects Pineapple Payments' Invoice Manager, an online invoice and bill presentment and payment solution, into the Payment Data Systems integration layer. This enables both organizations to offer increased convenience fee, payment plan and other invoice-centric functionality, enhancing each party's ability to differentiate and meet the bill delivery, payment acceptance, settlement and reconciliation needs of ISV's, merchants and consumers within the healthcare, education, and ambulatory market sectors. Furthermore, Pineapple's integration with Payment Data provides Pineapple access to automated and instant onboarding capabilities, both in mass as well as one customer at a time, through PayFac-in-a-Box, Payment Data Systems' proprietary payment facilitation platform. As a result, Pineapple plans to expand its value proposition for software vendors. Consequently, this agreement effectively broadens Payment Data Systems' distribution channels, having already added new software vendors initially representing $10 million of annual ACH and card processing volume. Vaden Landers, EVP and Chief Revenue Officer at Payment Data Systems, said, "We are thrilled to partner with Pineapple Payments to combine two best-in-class technologies that are highly complementary and synergistic to create virtually unmatched payment processing capabilities. Our payment facilitation platform will strategically serve Pineapple's current and prospective customer base by drastically simplifying the customer enrollment and onboarding experience while providing value-oriented, scalable technology that allows for payments to be collected in a variety of ways including on-line, via mobile phone, or in person. We are extremely enthusiastic to be moving forward with Brian Shanahan, Jon and the Pineapple team as we continue to focus on gaining traction within these bill-centric verticals and scale our PayFac technology." Shares of Payment Data Systems are up 7.08% or 15c to $2.27 per share in afternoon trading.
|
CIR CR | Hot Stocks13:33 EDT Circor again rejects Crane bid, says it 'substantially' undervalues company - Circor International (CIR) confirmed that it has previously received and rejected an "an unsolicited, non-binding" proposal from Crane Co. (CR) to acquire all the outstanding shares of Circor common stock for $45 per share in cash. Circor said in a statement, "Crane's proposal, which was publicized today, was received by CIRCOR on April 30, 2019. Consistent with its fiduciary duties and in consultation with its independent legal and financial advisors, CIRCOR's board of directors carefully reviewed that proposal. Following that review, the board of directors unanimously rejected Crane's proposal and determined that the proposal was highly opportunistic, substantially undervalued CIRCOR and its future prospects, and did not constitute a basis for engaging in further dialogue with Crane at this time." J.P. Morgan is acting as financial advisor to Circor.
|
CIR CR | Hot Stocks13:30 EDT Circor 'reiterates rejection' of takeover proposal from Crane
|
PXD | Hot Stocks13:26 EDT Pioneer Natural backs Q2 Permian production view 313-328 MBOEPD - Backs Q2 Permian oil production view of 198-208 MBOPD.
|
CIR | Hot Stocks13:25 EDT CIRCOR trading halted, news pending
|
PXD | Hot Stocks13:25 EDT Pioneer Natural sees FY19 Permian production 320-335 MBOEPD - Sees FY19 cash flow $3.75B. Sees FY19 Permian budget $2.8B-$3.1B. Sees FY19 Targa Midlan Basin EBITDA about $60M. Says evaluating water infrastructure, with Midland waste water plant expected to be completed by early 2021. Says targeting up to $100M in annual G&A savings. Says new organizational structure will support a single asset company. Comments taken from slides to be presented at the UBS Oil and Gas Conference.
|
LLY | Hot Stocks13:21 EDT Eli Lilly says mirikizumab for Crohn's met primary endpoint in Phase 2 study - Eli Lilly announced new safety and efficacy data for mirikizumab in patients with moderately- to severely active Crohn's disease. Patients treated with mirikizumab in the Serenity Phase 2 study achieved significant reductions in clinical and endoscopic measures of disease activity at 12 weeks compared to placebo, the company said in a statement. The maintenance phase of this study is ongoing. In the study, patients with moderately- to severely active Crohn's disease were randomized to receive either placebo or one of three doses of mirikizumab, which is an investigational antibody that targets the p19 subunit of interleukin 23. The primary endpoint evaluated mirikizumab versus placebo on endoscopic response, which was defined as a 50 percent reduction from baseline in the severity of each patient's disease, as measured by the Simple Endoscopic Score for Crohn's Disease. Secondary endpoints included clinical remission as measured by Patient Reported Outcomes (PRO remission), endoscopic remission, and safety. At 12 weeks, treatment with mirikizumab achieved rates of endoscopic response of 25.8%, 37.5% and 43.8% of patients in the 200 mg, 600 mg, and 1000 mg groups, respectively, achieved response compared to 10.9% of placebo patients. Across the three mirikizumab treatment groups, five patients, or 4%, reported one or more serious adverse event, and 81 patients, or 64%, reported one or more treatment emergent adverse event during the induction phase of the trial.
|
AAPL INTC | Hot Stocks13:04 EDT Apple announces launch of 'fastest Mac notebook ever,' the 8-core MacBook Pro - Apple (AAPL) announces that it has updated MacBook Pro with faster 8th- and 9th-generation Intel (INTC) Core processors, "bringing eight cores to MacBook Pro for the first time." The company said: "MacBook Pro now delivers two times faster performance than a quad-core MacBook Pro and 40 percent more performance than a 6-core MacBook Pro, making it the fastest Mac notebook ever." Starting at $1,799 and $2,399 respectively, the updated 13-inch MacBook Pro with Touch Bar and 15-inch MacBook Pro are available today through apple.com and the Apple Store app and in select Apple Stores and Apple Authorized Resellers later this week.
|
NURO | Hot Stocks13:03 EDT NeuroMetrix announces issuance of new U.S. patent for Quell wearable technology - NeuroMetrix announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,293,159 titled "Measuring the 'on-skin' time of a Transcutaneous Electrical Nerve Stimulator device in order to minimize skin irritation due to excessive uninterrupted wearing of the same." The patent covers novel methods to help Quell users safely obtain wearable TENS therapy over extended time periods. The patent includes claims for methods to monitor the amount of time that the Quell device is worn by a user and to provide the user with personalized notifications. "We are pleased to have received this latest patent for Quell technology," said Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix. "Quell is unique in the fact that the technology is designed for up to 24/7 use and therefore safe management of the skin-device interface is important. This patent covers methods that address and personalize this requirement."
|
LUV | Hot Stocks12:41 EDT Mechanics union votes to ratify tentative agreement with Southwest - According to voting results posted on the Aircraft Mechanics Fraternal Association website, the votes for the AMFA - Southwest Airlines Aircraft Maintenance Technician Tentative Agreement Ratification Referendum were tallied on May 21, 2019. Votes for this referendum were counted and certified by ElectionBuddy, with 94.62% of votes in favor and 5.38% in opposition. Reference Link
|
MVBF | Hot Stocks12:33 EDT MVB Financial elects David Alvarez as chairman of the board - The Board of Directors of MVB Financial has elected David B. Alvarez as Chairman of the Board and has announced the appointment of Cheryl Spielman as a Member of the Board. Alvarez had served as Interim Chairman since August 2018, following the death of former Chairman Stephen R. Brooks. Alvarez is a recognized owner, business leader and established entrepreneur who remains active in development, industry and community work. He earned a Bachelor of Science in Business Administration degree from West Virginia University. Early in his career, he was instrumental in growing the family's business into a well-respected company, primarily serving the North Eastern natural gas markets and bridge construction throughout West Virginia. Alvarez has started and grown a number of successful companies that continue to benefit North Central West Virginia, Southwestern Pennsylvania and Northern Virginia.
|
TTD | Hot Stocks12:32 EDT Trade Desk names Jonathan Carson chief revenue officer - The Trade Desk announced the appointment of Jonathan Carson as the company's first Chief Revenue Officer. Based in the New York office, Carson is focused on driving the company's revenue generation and new client acquisition strategy. In this new role, Carson is responsible for scaling The Trade Desk's business development organization to continue the company's rapid global growth. Carson will report directly to CEO and Founder, Jeff Green. Prior to joining The Trade Desk, he served as the Chief Revenue Officer of Vevo.
|
WMB | Hot Stocks12:10 EDT Williams director Stephen Chazen purchases over $273K in company stock - Williams Companies director Stephen Chazen disclosed in a filing that he had purchased 10,000 shares of company stock at an average price of $27.33 per share on May 20. The total transaction value of the purchase was $273,275.
|
AJG | Hot Stocks12:04 EDT Arthur J. Gallagher acquires RPA Insurance, Innovative Coverage Concepts - Arthur J. Gallagher announced the acquisition of Parsippany, N.J.-based RPA Insurance Services, LLC and Innovative Coverage Concepts, LLC. Terms of the transactions were not disclosed. RPA Insurance Services provides insurance and risk management services to the Restaurant and Hospitality industry. RPA operates from offices in New Jersey, California, Colorado, Pennsylvania and Florida. Innovative Coverage Concepts is a program manager and managing general agency focused exclusively on developing and delivering specialized insurance programs for restaurants of all types throughout the United States.
|
HOME | Hot Stocks12:00 EDT At Home Group falls -8.9% - At Home Group is down -8.9%, or -$2.04 to $20.86.
|
KSS | Hot Stocks12:00 EDT Kohl's falls -10.9% - Kohl's is down -10.9%, or -$6.88 to $56.03.
|
MNK | Hot Stocks12:00 EDT Mallinckrodt falls -25.5% - Mallinckrodt is down -25.5%, or -$3.33 to $9.71.
|
QD | Hot Stocks12:00 EDT Qudian rises 16.0% - Qudian is up 16.0%, or 98c to $7.12.
|
DY | Hot Stocks12:00 EDT Dycom rises 16.6% - Dycom is up 16.6%, or $7.58 to $53.13.
|
CIR | Hot Stocks12:00 EDT Circor rises 41.7% - Circor is up 41.7%, or $12.79 to $43.45.
|
TJX | Hot Stocks11:39 EDT TJX management says no updated guidance on store counts 'as of now'
|
KR | Hot Stocks11:33 EDT Kroger, Loop announce exclusive grocery retail partnership - The Kroger Co. and Loop, a circular e-commerce platform developed by TerraCycle, announced an exclusive grocery retail partnership agreement in the United States, advancing Kroger's zero-waste vision by reducing single-use plastics in the environment. Through this partnership, Kroger and Loop will pilot the new reusable packaging system, enabling customers in select markets to purchase more than 100 products from consumer brands that have been redesigned with durable containers.
|
TJX | Hot Stocks11:15 EDT TJX saw small impact due to tariffs, management monitoring developments closely - Comments provided during Q1 earnings conference call.
|
CSX | Hot Stocks11:02 EDT CSX announces appointment of Farrukh Bezar as Chief Strategy Officer - CSX Corporation announced the appointment of Farrukh Bezar as senior vice president and chief strategy officer. His appointment is effective May 29, and he will report to Jim Foote, president and CEO. Bezar most recently served as founder and managing partner of transportation and logistics advisory firm Lynwood Partners.
|
ABT | Hot Stocks10:52 EDT Abbott reports late-breaking data from TRILUMINATE study presented at EuroPCR - Abbott announced "positive" late-breaking data from its TRILUMINATE study of the company's minimally invasive tricuspid valve repair system. Results at 30 days demonstrated that the investigational device is associated with a reduction of tricuspid regurgitation symptoms - caused by a leaky tricuspid heart valve - suggesting a possible treatment option for people suffering from this difficult-to-manage structural heart disease, the company said. Results from the TRILUMINATE study were presented in a late-breaking trial session at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions.
|
TSLA | Hot Stocks10:41 EDT Adam Koszary says joining Tesla as Social Media Manager - Adam Koszary of The Museum of English Rural Life tweeted: "So I have more news: I'm no longer moving to the Royal Academy. Instead, I'll be Tesla's Social Media Manager from July." Reference Link
|
IAC... | Hot Stocks10:33 EDT IAC's Dotdash partners with Masco subsidiary to launch paint for sale on Amazon - The Spruce, a brand of IAC (IAC) operating company Dotdash, announced the launch of a new interior and chalky finish paint line, The Spruce Best Home. Developed in partnership with KILZ, a subsidiary of Masco (MAS), the line "was created for today's generation of painters interested in sprucing up their home, reviving their furniture, and adding personality to their living space with fresh colors, textures, and looks," Dotdash stated. The Spruce Best Home paints will be available for purchase on Amazon (AMZN) this Friday, May 24, Dotdash announced.
|
KSS | Hot Stocks10:04 EDT Kohl's CEO says tariff increase wasn't considered in original FY19 guidance
|
KSS | Hot Stocks10:00 EDT Kohl's management 'disappointed' in increase in tariffs to 25% from 10% - Kohl's CFO Bruce Besanko says tariffs primarily affect China-sourced merchandise in home and accessories business. Apparel and footwear are not impacted at this point. Besanko added that China is not the company's largest source of merchandise but it is "a big one" at "a little over 20%" of the company's goods. Besanko said the company will take a "prudent approach in terms of modeling these tariffs." CEO Michelle Gass added, "it's fair to say it's still a very fluid situation, right now." Gass said, teams are working "very closely" with vendors to ensure they have a "strong plan."
|
HOME | Hot Stocks10:00 EDT At Home Group falls -7.5% - At Home Group is down -7.5%, or -$1.72 to $21.18.
|
KSS | Hot Stocks10:00 EDT Kohl's falls -11.7% - Kohl's is down -11.7%, or -$7.34 to $55.57.
|
MNK | Hot Stocks10:00 EDT Mallinckrodt falls -32.5% - Mallinckrodt is down -32.5%, or -$4.24 to $8.79.
|
QD | Hot Stocks10:00 EDT Qudian rises 10.4% - Qudian is up 10.4%, or 64c to $6.78.
|
DY | Hot Stocks10:00 EDT Dycom rises 15.7% - Dycom is up 15.7%, or $7.17 to $52.72.
|
CIR | Hot Stocks10:00 EDT Circor rises 44.6% - Circor is up 44.6%, or $13.66 to $44.33.
|
HD | Hot Stocks09:59 EDT Home Depot says falling lumber prices could cut FY sales by $800M - Says: Too early in year to predict what will happen with lumber prices... Sees "promise" in lumber during back half of year... Sees Q2 comps higher than Q1... China tariff hike to 25% to cost ~ $1B... Impact of tariffs "manageable"... Sees FY19 tax rate ~ 25.5%... Sees flat inventory turns.
|
SWI | Hot Stocks09:47 EDT SolarWinds falls -6.1% - SolarWinds is down -6.1%, or -$1.16 to $18.00.
|
KSS | Hot Stocks09:47 EDT Kohl's falls -12.8% - Kohl's is down -12.8%, or -$8.02 to $54.89.
|
MNK | Hot Stocks09:47 EDT Mallinckrodt falls -29.6% - Mallinckrodt is down -29.6%, or -$3.86 to $9.17.
|
AMRX | Hot Stocks09:47 EDT Amneal Pharmaceuticals rises 9.1% - Amneal Pharmaceuticals is up 9.1%, or 75c to $9.01.
|
DY | Hot Stocks09:47 EDT Dycom rises 14.4% - Dycom is up 14.4%, or $6.58 to $52.13.
|
CIR | Hot Stocks09:47 EDT Circor rises 49.4% - Circor is up 49.4%, or $15.14 to $45.80.
|
SMRT | Hot Stocks09:36 EDT Stein Mart rallies 22% to $1.15 after announcing in-store Amazon Hub Lockers
|
SMRT AMZN | Hot Stocks09:36 EDT Stein Mart installing Amazon Hub Lockers in nearly 200 stores - Stein Mart (SMRT) announced that it is installing Amazon Hub Lockers in nearly 200 of its stores across 28 states. "Amazon Hub Lockers are secure, self-service kiosks that provide customers of the online retailer an alternative delivery option to pick up and return their Amazon packages," the company said in a statement. "We are thrilled to offer this innovative delivery experience to Amazon customers while introducing new shoppers to Stein Mart," said Hunt Hawkins, Stein Mart's CEO. Patrick Supanc, Amazon Worldwide Director of Lockers and Pickup, added, "Amazon will go where our customers are and deliver where and when they need us. Rolling out Amazon Hub Lockers with Stein Mart is a great opportunity to provide a seamless shopping and delivery experience for our joint customers." Stein Mart said the lockers will be available by early June.
|
TYL | Hot Stocks09:27 EDT Tyler Technologies signs $20M SaaS agreement with Bexar County, Texas - Tyler Technologies announced that it has signed a five-year, $20M agreement with Bexar County, Texas, for several modules of its Odyssey solution, including Odyssey Case Manager, Odyssey Attorney Manager, Odyssey Financial Manager, Odyssey Judge Edition, Odyssey Clerk Edition, and Odyssey Jury, along with Tyler Corrections, Tyler Supervision, and SoftCode civil process solutions. This agreement represents Tyler's largest software-as-a-service contract to date.
|
HD | Hot Stocks09:26 EDT Home Depot says has not included impact of tariffs in FY19 guidance - Says: Working through impacts of tariffs... Has not included impact of tariffs in FY19 guidance... Drivers for home improvement spending "strong."
|
KSS AMZN | Hot Stocks09:26 EDT Kohl's CEO says all stores to begin accepting Amazon returns in July - Kohl's (KSS) CEO Michelle Gass says the Amazon (AMZN) returns program is "all about driving traffic." Gass added that the company will invest in additional staffing and logistics to support the returns process. Gass said the company's expanded relationship with Amazon is structured in a way that both companies will benefit from driving long-term success of the program.
|
KSS | Hot Stocks09:21 EDT Kohl's sees low single-digit percentage dip in inventory levels in USD in 2019
|
KSS AMZN | Hot Stocks09:19 EDT Kohl's sees Q2 SSS 'to remain soft but show relative improvements to Q1' - Kohl's (KSS) management expects growth to resume in second half of the year, driven by an incremental sales increase related to the Amazon (AMZN) returns program along with program expansions and important bran launches.
|
ROG | Hot Stocks09:17 EDT Rogers comments on U.S. Department of Commerce entity list designation of Huawei - Rogers commented that it has evaluated the recently issued U.S. Department of Commerce export control restrictions relating to Huawei Technologies and its affiliates and is implementing additional compliance processes for sales to Huawei's fabricators and converters, which are Rogers' direct customers. "However, because of the uncertain impact of the new restrictions on Huawei's global supply chain, it is unclear how demand for Rogers' products may be affected. Accordingly, the company is unable to determine what impact, if any, this may have on its financial performance for the second quarter of 2019. The company will continue to monitor these developments and seek to maintain compliance with applicable laws."
|
HD | Hot Stocks09:16 EDT Home Depot says sales performance 'came in below expectations' - Says: This was a "noisy" quarter... Saw growth in ticket and transactions... Making investments from a position of strength... Online traffic growth was "healthy"... 23% growth in online business... Pro customer outpaced DIY during the quarter... Value proposition for Pro customer is "unique"... Continue to invest in tool-renting experience... Big ticket transactions up 3.9%, big ticket comps up 5.1%. Comments from company's Q1 earnings conference call.
|
HRTX | Hot Stocks09:16 EDT Heron Therapeutics announces publication of results from Phase 3 EPOCH 1 - Heron Therapeutics announced that the results from the pivotal Phase 3 EPOCH 1 bunionectomy study of the investigational agent HTX-011 have been published online by the Regional Anesthesia & Pain Medicine journal. The article, entitled "HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in bunionectomy: phase III results from the randomized EPOCH 1 study," also will be published in the July 2019 print issue of RAPM. HTX-011 achieved all primary and key secondary endpoints in the EPOCH 1 study, demonstrating statistically significant reductions in both pain intensity and the use of opioid rescue medications following surgery and an increase in the proportion of patients who were opioid-free.
|
AVCO | Hot Stocks09:15 EDT Avalon GloboCare enters research, licensing agreement with MIT - Avalon GloboCare has entered into a sponsored research and licensing agreement with Massachusetts Institute of Technology, or MIT, to generate novel therapeutic targets for cellular therapy using artificial intelligence, or AI, enhanced protein design technology. This technology of "QTY Code" greatly enhances the solubility of designer peptides and proteins, therefore expanding the repertoire of selected therapeutic targets against cancers and other diseases. Avalon will initiate research and development with MIT professors to design the next generation of therapeutics for Cytokine Release Syndrome, T-cell leukemia, as well as novel methodology to re-engineer immune cells for cellular immunotherapy.
|
PRGO | Hot Stocks09:15 EDT Perrigo receives approval from FDA for Voltaren Gel - Perrigo Company announced its partner received final approval from the FDA for its AB rated Abbreviated New Drug Application referencing Voltaren Gel, 1%. Perrigo will acquire full ownership of the ANDA under a pre-existing arrangement with its partner within 30 days. The Company anticipates launching this product within the next two months. Annual market sales for Voltaren(R) Gel, 1% for the 12 months ending March 2019 were approximately $350M as measured by IQVIA. Perrigo will manufacture diclofenac sodium topical gel 1% in its plant in Israel. The product was developed through its partnership with Capstone Development Solutions, a company of Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry.
|
OPTT | Hot Stocks09:12 EDT Ocean Power regains compliance with Nasdaq - Ocean Power announced that it has received written notification from the Nasdaq Hearings Panel notifying the company that it has regained compliance with the minimum shareholders' equity rule and further, that the company complies with all other applicable standards for continued listing of its securities on Nasdaq and that the panel considers this matter closed.
|
RBA | Hot Stocks09:10 EDT Ritchie Bros. receives approval of TSX and announces share repurchase program - Ritchie Bros. Auctioneers announces that it has obtained the approval of the Toronto Stock Exchange, or TSX, to commence a normal course issuer bid, or NCIB. The NCIB will allow the Company to use its share repurchase program to primarily neutralize share dilution from options.The NCIB will commence on May 23 and will terminate on May 22, 2020 or on such earlier date as the Company may complete its purchases thereunder or as it may otherwise determine. Under the NCIB, the Company may purchase up to the lesser of 5,449,204 common shares and that number of common shares worth an aggregate of $100M. Furthermore, subject to certain exemptions for block purchases, the maximum number of its common shares that the Company may purchase on any one trading day on the TSX is 31,957 common shares, such amount representing 25% of the average daily trading volume of the common shares of the Company on the TSX alone for the six calendar months ended April 30.
|
FPAY | Hot Stocks09:09 EDT FlexShopper receives extension from Nasdaq to regain compliance - FlexShopper announced that Nasdaq has determined that the company is eligible for a 180-day grace period, or until November 18 to regain compliance with its bid price rule.
|
MSI | Hot Stocks09:09 EDT Motorola Solutions says USPTO upholds validity of additional patent - Motorola Solutions announced that the Patent Trial and Appeal Board of the United States Patent and Trademark Office issued a final written decision in the reexamination of Motorola Solutions' U.S. Patent No. 8,279,99, which relates to Motorola Solutions' time-division multiple access technology. The PTAB rejected all validity challenges related to the patent raised by Hytera Communications. Importantly, the '991 patent enables key functionality that provides Motorola Solutions' customers with innovative capabilities that ensure products are highly reliable, safe and efficient. This decision marks the PTAB's rejection of Hytera's fourth attempt to invalidate Motorola Solutions' patents, including three patents that the International Trade Commission found Hytera was intentionally infringing. After losing in the ITC, Hytera vigorously pursued its bid in the USPTO to invalidate Motorola Solutions' patents U.S. Patent Nos. 6,591,111; 7,369,869; 8,116,284; and 8,279,991. With the PTAB's announcement of its decision on the '911 patent, the PTAB has now rejected all four of Hytera's challenges. All four of these patents are currently asserted by Motorola Solutions against Hytera in a patent litigation lawsuit pending in United States District Court in Chicago, Illinois. In that suit, Motorola Solutions is seeking an injunction against Hytera's "i-Series" product line. Notably, Hytera's i-Series was released in response to the ITC orders banning Hytera's prior products from being imported into the United States. Hytera has removed from its i-Series products key features covered by Motorola Solutions' patents, significantly impacting performance. As a result of the PTAB's orders, Hytera will be precluded from raising certain prior art invalidity defenses in the District Court proceedings.
|
KSS | Hot Stocks09:07 EDT Kohl's planning more conservatively going forward due in part to tariffs - Management is confident that initiatives will add to incremental sales in second half of the year. Comments provided during Q1 earnings conference call.
|
BLPH | Hot Stocks09:06 EDT Bellerophon presents additional data from INOpulse study at ATS - Bellerophon presented additional data from Cohort 1 of its ongoing Phase 2/3 randomized, double-blind, placebo-controlled clinical study of INOpulse for the treatment of Pulmonary Hypertension associated with Interstitial Lung Disease, or PH-ILD, as a late-breaking oral presentation at the American Thoracic Society, or ATS. MVPA improved by 34%. Overall activity improved by 12%. NT-ProBNP improved by 27%. NT-ProBNP is a peptide marker of right ventricular failure, with higher levels indicative of disease worsening. Oxygen saturation improved by 20%. The 34% placebo corrected improvement in MVPA was supported by separation between subjects on iNO and subjects on placebo. Proportion of awake time spent in MVPA improved by 38%. Calorie expenditure improved by 12%. Subjects on open-label extension demonstrated consistent improvements in MVPA and overall activity, with subjects transitioning from placebo to open-label experiencing a reversal from worsening to improving.
|
STT | Hot Stocks09:05 EDT Charles River Development,, Neptune Networks announce strategic collaboration - Charles River Development, a State Street Company, and Neptune Networks announced a strategic collaboration that will provide buy-side clients of Charles River's Order and Execution Management System with aggregated, real-time fixed income axes and inventory. Neptune provides technology solutions that enable real-time connectivity and deliver high-quality bond market data from sell-side banks to buy-side clients.
|
CIR... | Hot Stocks09:03 EDT Fly Intel: Pre-market Movers - HIGHER: Circor (CIR), up 51% to $46.35 after Crane (CR) announced that it has submitted a proposal to the board of Circor to acquire the company for $45 per share in cash... Boeing (BA), up 2% after the Wall Street Journal reported U.S. aviation authorities regard a collision with one or more birds as the most likely reason for trouble with an "angle of attack" sensor that ultimately caused the Ethiopian Airlines crash of a 737 MAX jet. UP AFTER EARNINGS: AutoZone (AZO), up 2%... 360 Finance (QFIN), up 8%. DOWN AFTER EARNINGS: Home Depot (HD), down 1%... Kohl's (KSS), down 10%... J.C. Penney (JCP), down 11%... Nordson (NDSN), down 3%. LOWER: BioCryst (BCRX), down 47% after announcing results from Phase 3 APeX-2 trial.
|
ADMP | Hot Stocks09:01 EDT Adamis Pharmaceuticals announces patent litigation regarding naloxone injection - Adamis Pharmaceuticals announced that it received notice that it had been named and served as a defendant in a lawsuit filed by Kaleo Inc. in the United States District Court for the District of Delaware regarding Adamis' higher dose naloxone injection product candidate for the treatment of opioid overdose, for which Adamis has previously submitted a new drug application, or NDA, to the FDA that is being reviewed by the agency. The complaint alleges, among other things, that the company's product candidate infringes patents purportedly held by Kaleo relating to its naloxone auto-injector product. The action was filed under the provisions of the Hatch-Waxman Act in response to Adamis' Paragraph IV certification regarding the Kaleo patents as part of the company's NDA process, and results in an automatic stay of any final approval by the FDA of Adamis' NDA. Adamis does not anticipate this stay would interrupt or delay the FDA's ongoing review of the NDA; however, if the patent dispute is unresolved by the time the FDA was prepared to grant an approval, the company believes that the agency would grant conditional approval until the sooner of October 4, 2021 or until final resolution of the matter before the court, whichever occurs sooner. Adamis believes that its naloxone injection product, which combines a generic formulation of naloxone with Adamis' proprietary injection device, does not infringe any valid and enforceable patent held by Kaleo and that Kaleo's complaint is without merit. Adamis intends to defend against Kaleo claims and pursue all available legal remedies available to the company against Kaleo and, if appropriate, its outside counsel.
|
ORMP | Hot Stocks08:56 EDT Oramed completes enrollement for Phase IIb clinical study of its insulin capsule - Oramed Pharmaceuticals announced that it has completed enrollment for its 90-day dose-ranging Phase IIb clinical study of its oral insulin capsule main cohort. Close to 300 patients have now been enrolled. 70%, over 200, of these patients have completed treatment in the study. The Phase IIb double-blind, randomized study for Type 2 diabetes was designed to identify the optimal dose to take into Phase III studies. A primary efficacy endpoint of reduction in HbA1c as well as safety endpoints are being assessed. A previous 28-day treatment study of 180 patients revealed a statistically significant improvement from baseline in HbA1c levels. Longer term treatment with ORMD-0801 has the potential for a more significant positive impact on HbA1c, a key clinical measure of blood sugar.
|
JBL RNLSY | Hot Stocks08:51 EDT Jabil announces additive manufacturing agreement with Renault F1 team - Jabil (JBL) announced an additive manufacturing agreement with Renault F1 Team (RNLSY) to speed the development and delivery of 3D-printed racecar parts for the Renault R.S.19, competing in the 2019 Formula One World Championship. "Through the Jabil Additive Manufacturing Network, Renault F1 Team will gain fast and efficient access to top-quality parts.
|
RESI | Hot Stocks08:50 EDT Front Yard Residential enters agreement with Snow Park Capital Partners - Front Yard entered into an agreement with Snow Park that provides for the appointment of Messrs. Abrams and Nikolic to the Front Yard Board, Snow Park's withdrawal from the proxy contest and Snow Park's agreement to customary standstill provisions, among other items. CEO George Ellison stated: "These initiatives are the result of constructive dialogue between the Company and its stockholders. We welcome Leland and Lazar to the Board and look forward to working with them to achieve our goals. Our new directors bring additional experience, independence and fresh perspectives, which we expect will help Front Yard deliver superior stockholder returns."
|
RESI | Hot Stocks08:49 EDT Front Yard Residential forms board committee to explore strategic alternatives - The company said, :Front Yard has been executing on a strategy to unlock what we believe is imbedded value in our assets and platform. Despite these efforts, Front Yard does not believe its current share price accurately reflects the value of the company. To maximize value for shareholders, Front Yard also announced that the Board will form a committee, comprised of independent directors to explore strategic alternatives. The Committee intends to review strategic alternatives available to Front Yard, including, without limitation, the potential internalization of the asset management function, the potential termination of the asset management agreement with Altisource Asset Management Corporation and the potential sale of the Company. Deutsche Bank Securities Inc. has been retained as an independent financial advisor to assist in the exploration of a full range of strategic alternatives. Front Yard intends to update its stockholders on further developments after the Committee concludes its review of strategic alternatives, or it has otherwise determined that disclosure is appropriate."
|
CIZN | Hot Stocks08:48 EDT Citizens Holding acquires Charter Bank - Citizens Holding, the parent company of The Citizens Bank of Philadelphia, announced the signing of a definitive merger agreement to acquire Charter Bank. Upon completion of the merger, Charter will merge into Citizens Bank. Based upon financial data as of March 31, the combined company will have approximately $1.2B in assets, deposits of $989M, and gross loans of $569M. The merger is expected to close in Q4, pending customary closing conditions, including receipt of required regulatory approvals and the approval by the shareholders of Charter. Subject to the terms of the merger agreement, Charter shareholders will receive 0.39417 shares of Citizens' common stock and $3.615 in cash for each outstanding share of Charter common stock. Based on Citizens' closing price of $20.90 as of May 20, this equates to a per share value of $11.85 and an aggregate deal value of $20M. At March 31, Charter had approximately $161M in total assets, $134M in deposits and $110M in gross loans. Charter operates four branches in the counties of Harrison and Jackson, Mississippi. The combination expands Citizens' presence in its southern markets, creating the 10th largest bank by deposits in the combined counties of Hancock, Harrison and Jackson, otherwise known as the Mississippi Gulf Coast. Upon completion of the merger, Gregory Cronin, CEO of Charter, will serve in a leadership position with Citizens. "Our Charter Bank Team is enthusiastic to be joining a well-respected community bank with a history of providing exceptional products and services to its markets," remarked Cronin. "We believe that we can better serve our clients in our local communities."
|
RESI | Hot Stocks08:48 EDT Front Yard Residential increases board to eight directors - Front Yard has agreed to appoint two new independent directors, Leland Abrams and Lazar Nikolic, to the Company's Board of Directors immediately following the Company's Annual Meeting of Stockholders on May 23, 2019. Concurrently, David Reiner will be retiring from the Board. With these changes, Front Yard's Board will increase from seven to eight directors, seven of whom are independent. Snow Park has agreed to vote for Front Yard's entire slate of director nominees at the Company's upcoming annual meeting and to withdraw its proxy contest.
|
RESI | Hot Stocks08:47 EDT Front Yard Residential enters agreement with Snow Park Capital Partners - Front Yard Residential Corporation announced several new strategic initiatives that it said it "believes will position Front Yard for ongoing success and support its efforts to maximize value for all stockholders." In conjunction with these new initiatives, Front Yard announced it has reached an agreement with Snow Park Capital Partners and certain of its affiliates with respect to its director nominees and certain other matters.
|
CLRB | Hot Stocks08:42 EDT Cellectar Biosciences to expand third cohort of CLOVER-1 study - Cellectar Biosciences announced that initial results from the third cohort of its ongoing Phase 2 CLOVER-1 study of CLR 131 have exceeded its pre-specified performance criteria. As a result, the company will expand the number of chronic lymphocytic leukemia/small lymphocytic lymphoma, lymphoplasmacytic lymphoma and marginal zone lymphoma patients it will enroll in the cohort. The company continues to expect to report top-line data from the Phase 2 CLOVER-1 study in 2019.
|
CGC... | Hot Stocks08:39 EDT Canopy Growth appoints Mike Lee as acting CFO, effective June 1 - Canopy Growth (CGC) is pleased to announce the appointment of Mike Lee to its executive leadership team in the acting role of CFO, effective June 1. Mike's permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the company. Mike brings a wealth of experience from the consumer goods & beverages industry, having worked for companies such as E. & J. Gallo Winery, PepsiCo (PEP), and recently Constellation Brands (STZ), where he served as Senior Vice President & CFO for their $3B Wine & Spirits Division.
|
AMRS | Hot Stocks08:39 EDT Amyris executes strategic supply agreements with Raizen - Amyris announced the execution of strategic supply agreements with Raizen for the supply of sugar, energy and other utilities to its new planned production plant co-located with Raizen's Barra Mill at Barra Bonita, Brazil. In addition to the supply agreements, the companies entered into an arrangement to establish the basis for the creation of a potential joint venture between Amyris and Raizen, focused on the production and commercialization on a global basis of zero calorie sweeteners using Amyris's technology, naturally sourced from sugar cane sugar. This potential joint venture would leverage from Raizen's scale in feedstock, operating, sugar market know how and access, supply chain businesses and power generation. For Raizen, the joint venture is expected to provide strategic innovation and product diversification, through the development of high value products sourced from sugar cane and biomass. The creation of the potential joint venture is subject to the fulfillment of certain conditions established between the parties, as well as all the applicable approvals from regulatory and antitrust authorities.
|
SANM | Hot Stocks08:35 EDT Sanmina and Smiota announce partnership - Sanmina and Smiota announced a partnership to offer smart locker solutions for the secure exchange of physical goods across a wide range of industry verticals such as Retail, Enterprise, Multi-family, and Universities. Sanmina's Mechanical Systems Division, or MSD, will support the hardware development and manufacturing of smart locker solutions, and Sanmina's Global Services Division, or SGS will provide installation services and field support. Smiota will provide its Locker Delivery Operating Systems, o L-DOS, and leading Smiota cloud platform to enable secure last-yard delivery of goods to smart lockers.The partnership enables Sanmina and Smiota to jointly deliver comprehensive smart locker solutions globally for secure, streamlined delivery of packages and groceries. M
|
ONCS | Hot Stocks08:32 EDT OncoSec granted worldwide rights to IL-12 DNA and other inhibitor therapies - OncoSec Medical announced that the Company has been granted exclusive worldwide rights to Gaeta Therapeutics' broad portfolio of patents and applications covering the combination use of IL-12 DNA and various checkpoint inhibitor therapies, including anti-CTLA-4 and anti-PD-1 compounds, in key global markets. IL-12 has emerged as an important pro-inflammatory signaling cytokine, which many other companies are now using to develop cancer immunotherapies with several different modalities. The exclusive rights OncoSec has secured in this patent portfolio cover the use of IL-12 DNA, in combination with checkpoint inhibitors, while pending applications are pursuing broader claims, across multiple jurisdictions.
|
CLIR | Hot Stocks08:32 EDT ClearSign Combustion receives contract from major California oil producer - ClearSign Combustion received an additional contract from a major California oil producer to retrofit another enclosed wellhead ground flare with its Duplex technology to ensure compliance with air district emission requirements. The project marks the seventh installation of ClearSign technology in the enclosed low emission ground flare and vapor combustor market.
|
JCP | Hot Stocks08:30 EDT J.C. Penney expects inventory to be a source of working capital in 2019
|
JCP | Hot Stocks08:26 EDT J.C. Penney says working to restore clearance selling margins - Says fine jewelry business continues to deliver strong results. Says children's apparel and men's apparel outpaced the company comp. Says maintaining focus and implementing actions and rigor surrounding inventory management to improve inventory productivity and gross margin levels and optimize working capital to increase cash flow. Says areas of focus include restoring clearance selling margins to more historical levels which represents significant total gross margin upside potential. Says normalizing shrink results to historical levels, Says could contribute meaningful total gross margin upside on an annualized basis. Says eliminating non-core and low gross margin product categories to refocus on driving higher sales and gross margin. Says recent category exits include major appliances, furniture and certain online drop-ship SKUs.
|
JCP M | Hot Stocks08:25 EDT J.C. Penney says 'minimal' impact from tariffs that have gone into effect - J.C. Penney (JCP) said on its Q1 earnings call t hat looking ahead, it anticipates a "more meaningful" impact on both its private and national brands if the potential fourth tranche of tariffs goes into effect on all Chinese imports. The Fly notes that Macy's (M) last week made similar comments on its earnings call, saying that the third tranche does have some impact, particularly on furniture business, but believes the impact can be mitigated. The retailer added that the fourth tranche, if enacted, would impact Macy's private and national brands and wasn't contemplated in guidance.
|
WW | Hot Stocks08:21 EDT WW announces new Toronto technology hub - WW announced a new technology hub that will be launched in Toronto to expand the Company's team working on the digital WW experience for its members. WW hired Don Kittle, Vice President, Engineering, previously with LoyaltyOne, Postmedia, Kijiji and Virgin Mobile, as its first Technology team member in Toronto. Kittle is building a team of engineering and data science talent to continue the technology transformation and personalization efforts underway. The team in Toronto will work collaboratively with the WW Product and Technology teams in New York and San Francisco, including designers, engineers, product managers, data scientists and researchers, on ways to personalize the WW experience.
|
JCP | Hot Stocks08:20 EDT J.C. Penney says enhancing apparel business will continue to be 'key focus' - Says beginning to see improved shrink results through recent technology implementations and staffing adjustments. Says new security tag implementations have each delivered meaningful reductions in shrink dollars in their respective areas. Says revamping and rethinking merchandise strategies, including the elimination of major appliances, to improve customer experience. Says held meetings with several key partners to discuss new ideas and initiatives. Says conducting an ongoing assortment review to better align apparel offerings with customer preferences and reestablish. Says refocusing efforts in Home and refining housewares and soft home assortment.
|
JCP | Hot Stocks08:17 EDT J.C. Penney sees improved overall gross margin performance in 2019 - Says working swiftly to build framework and team to reestablish fundamentals. Says made good progress on each of immediate action steps. Says reducing inventory levels. Says experienced significantly increased sell-thru rates within all divisions and delivered improved selling margins in majority of merchandise divisions. Says tested strategies around optimal inventory levels and assortment choice counts. Says removed several hundred thousand unproductive and unprofitable factory ship SKUs from jcp.com with relatively no impact to online sales results. Says l aunched a new store checkout process to streamline tasks and enhance the customer experience with shorter checkout lines. Says tested a new centralized pick-up and returns area with plans to expand the concept to 500 stores in Q2.
|
MTEC | Hot Stocks08:13 EDT MTech Acquisition Corp. announces Form S-4 statement declared effective by SEC - MTech Acquisition Corp. and MJ Freeway announced that MTech Acquisition's registration statement on Form S-4, which includes MTech's proxy statement in connection with the proposed merger between MTech and MJ Freeway under MTech Acquisition Holdings. to be renamed Akerna, was declared effective by the Securities and Exchange Commission, or SEC, on May 14. MTech stockholders will be requested to vote on the proposed merger with MJ Freeway.
|
GOOG... | Hot Stocks08:12 EDT Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi - Verily, an Alphabet (GOOG, GOOGL) company, announced strategic alliances with Novartis (NVS), Otsuka, Pfizer (PFE) and Sanofi (SNY) to develop digitally innovative, patient-centered clinical research programs using Project Baseline's evidence generation platform and tools. The Baseline Platform is designed to engage more patients and clinicians in research, increase the speed and ease of conducting studies and collect more comprehensive, higher quality data, including outside the four walls of a clinic. Across the United States, the number of people participating in clinical research -- including clinical trials and observational studies -- is less than 10% of the population.1 In addition to low participation, challenges in research include data fragmentation, inefficient operations and limited value for patients. Alongside academic research institutions, patient-advocacy groups and health systems, Verily and its industry partners aim to implement a more patient-centric, technology-enabled approach to research, and increase the number and diversity of clinical research participants. They will also explore novel approaches to generating real-world evidence using the Baseline Platform to collect, organize and activate health information from electronic health records, sensors and other digital sources. Over the coming years, Novartis, Otsuka, Pfizer and Sanofi each plan to launch clinical studies leveraging the platform across diverse therapeutic areas, such as cardiovascular disease, oncology, mental health, dermatology and diabetes. Verily's initial strategic alliances with Novartis, Otsuka, Pfizer and Sanofi strengthen the innovative research ecosystem that will continue to expand and could help foster greater scientific discovery through the creation of next-generation research and development programs.
|
DUK | Hot Stocks08:10 EDT Duke Energy receives NCUC approval for Hot Springs microgrid system - Madison County announces North Carolina Utilities Commission, or NCUC, approved Duke Energy's renewable energy project. In the town of Hot Springs, the company will proceed with a solar and battery-powered microgrid system that will help improve electric reliability, provide services to the overall electric system and serve as a backup power supply to the town of more than 500 residents. The Hot Springs microgrid will consist of a 2-megawatt solar facility and a 4-megawatt lithium-based battery storage facility. Together, the two projects will cost around $30M and should be operational in early 2020.
|
ABEO | Hot Stocks08:10 EDT Abeona Therapeutics announces FDA clearance of ABO-202 IND - Abeona Therapeutics announced that the company is cleared to begin a Phase 1/2 clinical trial evaluating its novel, one-time gene therapy ABO-202 for the treatment of CLN1 disease, following acceptance of its investigational new drug, or IND, application by the FDA. ABO-202 is designed to deliver a functional copy of the PPT1 gene to cells of the central nervous system and peripheral organs using a combined intravenous and intrathecal delivery via the AAV9 vector. The company will provide guidance on the timing of the clinical trial later this year. In preclinical studies, ABO-202 effectively delivered a functional copy of the PPT1 gene to the central nervous system and peripheral organs. IND-enabling studies in a CLN1 animal model demonstrated that ABO-202 normalized survival and led to improvement of neurological function in affected mice. These studies also showed that combination intravenous and intrathecal dosing provided incremental efficacy over either delivery route alone and thus may enhance the therapeutic potential of this gene therapy.
|
HPQ | Hot Stocks08:08 EDT HP Inc., Smile Direct Club collaborate on multi jet fusion 3D factory - HP Inc. and SmileDirectClub announced an expanded collaboration to revolutionize the way that millions of people can achieve a straighter smile. SmileDirectClub is powering its digital differentiation and rapid manufacturing expansion of clear aligners with HP's Jet Fusion 3D printing solutions, making it the largest producer of Multi Jet Fusion 3D printed parts in the country, the companies said in a statement. Alex Fenkell, co-founder, SmileDirectClub said "HP's breakthrough 3D printing and data intelligence platform makes this level of disruption possible for us, pushing productivity, quality, and manufacturing predictability to unprecedented levels, all with economics that allow us to pass on savings to the consumers seeking treatment using our teledentistry platform."
|
JCP | Hot Stocks08:08 EDT J.C. Penney says 'significant amount of work ahead of us' - Expects positive free cash flow for 2019. Says encouraged with progress made on key objectives. Comments taken from Q1 earnings conference call.
|
WTER | Hot Stocks08:08 EDT Alkaline Water announces distribution agreement with Premier DSD - Alkaline Water announced that it has entered into a new agreement with Premier National Food Distributors. Premier DSD has over 25 years of distribution experience and a nationwide network of over 1,000 direct store delivery, or DSD, routes. Premier DSD strengthens the company's presence in the convenience store channel, specifically in the Northeast market, including New York, Connecticut, Pennsylvania, Massachusetts and New Jersey.
|
QTNT | Hot Stocks08:07 EDT Quotient announces FDA approval of seven additional blood bank reagents - Quotient Limited announced the U.S. Food and Drug Administration has approved the commercialization of seven additional blood bank reagents for extended antigen typing, completing the company's core product offering to the US market. In March 2018, seven Quotient reagents were also approved by the FDA, including two market firsts. "Quotient has more than tripled our FDA approved product offering since coming directly to market in the U.S. We continue to be motivated to bring high-quality, customer-friendly products to the U.S. market, and are sincerely grateful to our customers for their ongoing support," said Bill Brady, VP US Commercial at Quotient.
|
OOMA RILY | Hot Stocks08:06 EDT Ooma agrees to acquire Broadsmart for $7.4M in cash - Ooma (OOMA) announced that it signed a definitive agreement on May 15, 2019, to acquire Broadsmart Global, a provider of cloud-based unified communications as a service solutions. Based in West Palm Beach, Florida, Broadsmart provides mid-sized and large enterprises with hosted voice service, audio and video conferencing, web collaboration, fiber connectivity, and SIP/IP trunking, along with network design and security solutions. Broadsmart serves customers throughout the United States and Canada. Broadsmart was previously a subsidiary of magicJack VocalTec, Ltd., a cloud-based Voice over Internet Protocol company, which was acquired by B. Riley Principal Investments, LLC, a wholly-owned subsidiary of B. Riley Financial, Inc. (RILY), in November 2018. The transaction is expected to close before the end of May and is subject to customary closing conditions. B. Riley FBR, Inc. acted as financial advisor to B. Riley on the transaction. Ooma has agreed to pay approximately $7.4M in cash for the acquisition of Broadsmart, subject to customary price adjustments.
|
JMU | Hot Stocks08:06 EDT JMU acquires Unicorn Investment Limited - JMU announced that the company has acquired Unicorn Investment Limited. Pursuant to a share purchase agreement, on May 21, JMU purchased all the issued and outstanding shares of Unicorn from its shareholder for the consideration of 632,660,858 newly issued ordinary shares of JMU. Unicorn is a developer of asset transaction platform products based on blockchain technologies. The former shareholder of Unicorn and the seller in the acquisition, Haohan Xu, is a principal shareholder of the company. Xu held 25.7% of all the issued and outstanding shares of the company immediately prior to the closing of the acquisition, and will hold approximately 48.0% of all the issued and outstanding shares of the company immediately after the closing of the acquisition.
|
POST | Hot Stocks08:06 EDT Post Holdings announces HSR termination for cereal business acquisiton - Post Holdings announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, as amended, with respect to the previously announced Post acquisition of the private label ready-to-eat cereal business of TreeHouse Foods. The termination of the waiting period under the HSR Act satisfies one of the closing conditions of the transaction. The transaction is now expected to be completed in July, subject to customary closing conditions.
|
ARCI | Hot Stocks08:06 EDT Appliance Recycling regains compliance with Nasdaq listing rules - Appliance Recycling Centers of America announced today that on May 20 it received notification from the Listing Qualifications Department of The Nasdaq Stock Market that the company regained compliance with Listing Rule 5550, which requires a minimum bid price of $1.00 per share. The company is now fully compliant with all Nasdaq rules. This matter is now closed.
|
SGEN | Hot Stocks08:06 EDT Seattle Genetics appoints Robin Taylor, Ph.D. as Chief Commercial Officer - Seattle Genetics (SGEN) announced the appointment of Robin Taylor, M.B.A., Ph.D., as Chief Commercial Officer. Most recently, he served as Vice President, Immuno-Oncology Franchise Head, Oncology Business Unit at AstraZeneca (AZN).
|
NVS... | Hot Stocks08:05 EDT Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi - Verily, an Alphabet (GOOG, GOOGL) company, announced strategic alliances with Novartis (NVS), Otsuka, Pfizer (PFE) and Sanofi (SNY) to develop digitally innovative, patient-centered clinical research programs using Project Baseline's evidence generation platform and tools. The Baseline Platform is designed to engage more patients and clinicians in research, increase the speed and ease of conducting studies and collect more comprehensive, higher quality data, including outside the four walls of a clinic. Across the United States, the number of people participating in clinical research -- including clinical trials and observational studies -- is less than 10% of the population.1 In addition to low participation, challenges in research include data fragmentation, inefficient operations and limited value for patients. Alongside academic research institutions, patient-advocacy groups and health systems, Verily and its industry partners aim to implement a more patient-centric, technology-enabled approach to research, and increase the number and diversity of clinical research participants. They will also explore novel approaches to generating real-world evidence using the Baseline Platform to collect, organize and activate health information from electronic health records, sensors and other digital sources. Over the coming years, Novartis, Otsuka, Pfizer and Sanofi each plan to launch clinical studies leveraging the platform across diverse therapeutic areas, such as cardiovascular disease, oncology, mental health, dermatology and diabetes. Verily's initial strategic alliances with Novartis, Otsuka, Pfizer and Sanofi strengthen the innovative research ecosystem that will continue to expand and could help foster greater scientific discovery through the creation of next-generation research and development programs.
|
STAR | Hot Stocks08:04 EDT iStar announces $112M transaction with Bowlero - iStar announced a $112M transaction with Bowlero, the largest operator of bowling entertainment venues in the world, consisting of the purchase of nine bowling centers for $57M and a commitment to purchase up to $55M of additional bowling centers over the next several years. The new centers will be added to two of iStar's existing master net leases with Bowlero. In connection with this transaction, the maturities of Lease I and Lease II were extended by 15 years to 2047. As a result of this transaction, the Company will revalue the properties originally subject to the leases at fair market value for financial reporting purposes, resulting in an expected gain in the Q2 in the range of $145M-$165M, subject to final valuations.
|
KOPN... | Hot Stocks08:04 EDT Kopin near eye microdisplay being utilized in Google Glass Enterprise Edition 2 - Kopin (KOPN) announced that its near eye microdisplay is being utilized by Google (GOOG, GOOGL) in its new Glass Enterprise Edition 2. Kopin was also the microdisplay supplier to Google's first generation Glass Enterprise Edition. "Glass Enterprise Edition 2 is a wearable computer that fits into the user's workflow to help them remain engaged and focused on their work. The headset is being used by companies to boost productivity, reduce costs and improve working conditions for employees."
|
ARRY | Hot Stocks08:04 EDT Array BioPharma: Phase 3 BEACON CRC trial met primary endpoints - Array BioPharma announced positive results from the interim analysis of the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI, MEKTOVI, and ERBITUX in patients with BRAFV600E-mutant metastatic colorectal cancer, following one or two prior lines of therapy. The trial met both primary endpoints of confirmed objective response rate, as assessed by Blinded Independent Central Review, and overall survival. Array intends to submit these results of the BEACON CRC trial for marketing approval in the second half of 2019. Results from the trial showed that BRAF-mutant mCRC patients treated with the BRAFTOVI Triplet demonstrated a statistically significant improvement in ORR (26.1% vs. 1.9%), and OS (median 9.0 months vs. 5.4 months), compared to cetuximab plus irinotecan-containing regimens.
|
VSAT | Hot Stocks08:02 EDT ViaSat awarded $450M contract by U.S. General Services Administration - Viasat announced it was awarded an IDIQ contract by the U.S. General Services Administration, or GSA, on April 18 with a maximum ceiling of $450M to support Rapid Migration of Command, Control, Communications and Computers/Cyber, or C5AD, Capability Best Practices for U.S. Special Operations Forces, or SOF, and U.S. General Purpose Forces, or GPF. Through this award, Viasat will deliver a diverse portfolio of technologies and services to advance communications, intelligence, security and operational capabilities for SOF and GPF warfighters operating across the battlespace.
|
AVYA | Hot Stocks08:02 EDT Avaya expands relationship with Collab9 - Avaya Holdings announced an acceleration of their ongoing relationship with Collab9, a best-of-breed, FedRAMP-authorized Unified Communications as a Service, or UCaaS, and Contact Center as a Service, or CCaaS, provider focused on the public-sector market. The two companies announced a go-to-market strategy that makes Collab9 the exclusive FedRAMP platform for Avaya in delivering Avaya OneCloud Contact Center, and Unified Communications and Collaboration solutions to federal, state and local government organizations across the U.S.
|
PPG | Hot Stocks07:54 EDT PPG finalizing cost program with about $125M of additional run-rate savings - "The two independent advisors performed thorough reviews and their similar conclusions clearly indicate the value of maintaining our current business portfolio, including architectural and industrial coatings, as the best strategic path to maximize shareholder value. By maintaining our current portfolio, we avoid negative commercial, operational and procurement impacts and preserve full strategic flexibility for the future," said CEO Michael McGarry. "As we have done consistently, we will continue our ongoing strategic assessment of all our businesses, ensuring each business continually earns its place in our portfolio based on current performance and future expectations. In addition, we recently concluded an engagement by a globally-recognized consulting firm focused on operational and growth investment reviews for our U.S. and Canada architectural coatings business, targeting full and rapid earnings recovery following the prior year customer assortment changes. Recommendations from this engagement include driving certain commercial network optimizations, implementing further cost structure improvements, utilizing additional sales effectiveness tools and adopting new digital technologies. We are executing these initiatives with the goals of achieving full recovery of our profitability next quarter and positioning the business for continued success. Also, while we remain a top quartile performer in our overhead and corporate cost structures, we conducted a rigorous internal operational and organizational review and identified certain opportunities for the company to further improve operating efficiency and maintain commercial excellence. As a result, we are working to finalize a new cost savings program with targeted full year run rate savings of about $125M. We expect to provide additional detail with the release of our second quarter financial results; however, the final program is expected to include: Further manufacturing optimization; Targeted pruning of low profit business in certain regions; Exiting certain smaller product lines that are not meeting profitability objectives; Reorganization of certain business unit cost structures based on current economic climate; Certain redundancy actions related to recent acquisitions; Second quarter charge in the range of $185M to $200M, excluding certain non-cash items."
|
CNI | Hot Stocks07:51 EDT Canadian National COO Mike Cory to retire, Rob Reilly to succeed - Canadian National announced the appointment, effective July 1, of new executive VP and COO Rob Reilly. Prior to his appointment as COO, Rob Reilly had 30 years of experience in the rail industry. He joined the Atchison, Topeka and Santa Fe Company in 1989. As part of these executive team changes, Mike Cory will retire as CN executive VP and COO on June 30 and will remain available to ensure a smooth transition.
|
PPG... | Hot Stocks07:51 EDT PPG to maintain current business portfolio composition after strategic review - PPG (PPG) announced that two separate and independent reviews of its business portfolio were completed by Goldman Sachs (GS) and Morgan Stanley (MS) with each firm independently conducting multi-faceted evaluations of PPG's business portfolio, including potential separation opportunities. PPG's Board of Directors and executive management team recently received a full report from each advisor with respect to their independent reviews. Based on these reports and its own evaluation, the Board has determined that maintaining the company's current business portfolio composition, including its architectural and industrial coatings businesses, provides the best opportunity to maximize long-term shareholder value.
|
MNK | Hot Stocks07:48 EDT Mallinckrodt down 11.7% to $11.50 after subsidiary files suit against HHS, CMS
|
PRIM | Hot Stocks07:47 EDT Primoris announces EPC award valued over $22M - Primoris announced a new engineering, procurement and construction, or EPC, award valued over $22M. The EPC award was secured by Primoris Design and Construction. The EPC project was awarded by a refinery customer for a project in New Mexico. The project includes an isomerization unit and recovery of saturated gas throughout the refinery for further processing within the existing refinery units. Primoris Industrial Constructors will perform construction for the project. Work is scheduled to begin immediately, and completion is estimated for Q3 of 2020.
|
JEC | Hot Stocks07:47 EDT Jacobs Engineering selected by WuXi Biologics as provider for new facility - Jacobs has been selected to provide construction management services for global biologics leader, WuXi Biologics, to support the development of its new biologics drug substance manufacturing facility located in Dundalk, Co. Louth, Ireland. The new facility, modelled on the "Factories of the Future" concept, will incorporate best-in-class innovative technology optimized for the flexible production of a wide range of biologic drugs for customers globally. Supported by the Irish Government through IDA Ireland, which they estimate to cost more than $394M, the project is expected to accelerate the development of biologics in Europe and help increase investment and jobs in Ireland under the Regional Action Plans for Jobs initiative. WuXi's investment will result in the creation of 400 highly skilled jobs over five years as well as approximately 700 construction jobs.
|
CRNX | Hot Stocks07:45 EDT Crinetics initiates Phase 1 study of CRN01941 - Crinetics announced the initiation of a Phase 1, double-blind, randomized, placebo-controlled, single- and multiple-dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of CRN01941 in healthy volunteers. CRN01941 is an oral nonpeptide somatostatin receptor subtype 2 biased agonist designed for the treatment of neuroendocrine tumors, or NETs, that originate from neuroendocrine cells commonly found in the gut, lung or pancreas. This Phase 1, double-blind, randomized, placebo-controlled, single-dose and multiple-dose study of CRN01941 will enroll up to 119 healthy male and female subjects.
|
MNRO AMZN | Hot Stocks07:43 EDT Monro, Amazon.com expand tire installation services collaboration - Monro (MNRO) announced it has expanded its collaboration with Amazon.com (AMZN) to provide tire installation services at over 400 additional Monro retail tire and automotive service locations in nine additional states across the central and western regions of the United States, more than doubling the amount of service locations to over 800 stores. Initially launched in the greater Baltimore area, these tire installation services are now available to customers who purchase tires from Amazon.com and select the ship-to-store option at over 800 locations operating under a number of Monro brands in 21 states across the United States. The new states added to the program include Arkansas, Delaware, Iowa, Kentucky, Minnesota, Missouri, New Jersey, Wisconsin and West Virginia. Monro remains on track to continue adding retail locations through FY20.
|
MNRO | Hot Stocks07:40 EDT Monro increases quarterly cash dividend 2c to 22c per share - Monro announced that its board has approved a 2c per share increase in the company's cash dividend for Q1 to 22c per share, which translates to an annual rate of 88c per share, representing an increase of 8c per share or 10% as compared to the total dividends paid in FY19. The cash dividend is payable quarterly to shareholders of record on the company's outstanding shares of common stock, including the shares of common stock to which the holders of the company's Class C convertible preferred stock are entitled. The dividend of 22c per share for Q1 will be payable on June 17 to shareholders of record as of June 3.
|
MGEN | Hot Stocks07:23 EDT Miragen Therapeutics to present new data from microRNA-29 mimic studies at ATS - Miragen Therapeutics announced that it will report new data demonstrating that systemic administration of its second-generation microRNA-29 mimic, the company's pre-clinical micro-RNA targeted therapeutic candidate for idiopathic pulmonary fibrosis, or IPF, reduced extracellular matrix deposition in a series of preclinical studies. The data will be presented at the American Thoracic Society, or ATS. In these studies, a chemically modified microRNA-29 replacement was studied in mice with bleomycin-induced fibrosis in their lungs, which is a well-established model of IPF. The compound was evaluated in both therapeutic and prophylactic dosing paradigms. Data from the studies demonstrated a down-regulation of certain pro-fibrotic genes that were previously established as targets of microRNA-29. These effects extended to downstream targets involved in the pro-fibrotic response, including connective tissue growth factor. The downregulation of these mechanistic biomarkers translated to the inhibition of the pro-fibrotic response as measured by quantitative histopathological analyses of whole lung scans. This resulted in an approximately 50% inhibition of collagen deposition. Additionally, animals treated with the compound showed normal alveoli architecture, which was not present in control mice.
|
JCP SFM | Hot Stocks07:19 EDT J.C. Penney appoints Shawn Gensch CCO - J.C. Penney (JCP) announced that Shawn Gensch, an executive with 25 years of experience in marketing and finance, has been named executive VP, chief customer officer, or CCO, effective June 3, reporting directly to Jill Soltau, CEO. He will be responsible for driving customer-centric strategies to grow traffic, engagement and customer retention in addition to revitalizing the company's brand, leading marketing initiatives across all channels, shaping the company's messaging and delivering digital experience and increased customer loyalty. In this role, Gensch will oversee all aspects of the company's marketing strategies and initiatives including digital, advertising, creative design, customer research, loyalty, analytics and insights, social media, sales promotions and planning and events marketing to deliver an integrated brand experience across all customer touchpoints. Gensch joins JCPenney from Sprouts Farmers Market (SFM) where he served as CCO, overseeing their brand and category marketing strategy, digital marketing, guest insights, customer relations, advertising, social media, private label brand strategy and public relations in support of its nationwide stores and e-commerce operations.
|
BCRX | Hot Stocks07:16 EDT BioCryst Phase 3 APeX-2 trial meets primary endpoint for both dose levels - BioCryst announced that the randomized, double-blind, placebo-controlled, Phase 3 APeX-2 trial of once-daily, oral BCX7353 for the prevention of hereditary angioedema, or HAE, attacks achieved its primary endpoint for both dose levels with the 150 mg dose reducing the attack rate in HAE patients by 44% compared to placebo. Fifty percent of patients receiving 150 mg BCX7353 in APeX-2 had a 70% reduction in their HAE attack rate compared to baseline, compared to 15% of placebo patients. In patients on the 150 mg dose with a baseline attack rate of less than 2 attacks per month, BCX7353 reduced the HAE attack rate by 66% compared to placebo. In patients with a baseline attack rate of two attacks per month, the attack rate was reduced by 40%. Of 108 patients who completed 24 weeks of study drug treatment, 100% continued into the ongoing 48 week extension phase of the trial. In APeX-2, both the 110 mg and 150 mg dose levels of once-daily oral BCX7353 were generally safe and well-tolerated. No drug-related serious adverse events were reported. The most common drug-related adverse events reported in at least five percent of patients in APeX-2 were: nausea, dyspepsia and diarrhea. The results from APeX-2 support the submission of a new drug application, or NDA, to the FDA. BioCryst plans to submit an NDA to the FDA in Q4 and a marketing authorization application, or MAA, to the European Medicines Agency in Q1 of 2020.
|
PDCE | Hot Stocks07:15 EDT Kimmeridge responded to PDC's Energy claims regarding conflicts of interest - Kimmeridge Energy Management Company and certain of its affiliates, beneficial owners of 5.1% of the shares of common stock of PDC Energy, responded to PDC's false claims regarding independence and conflicts of interest. Kimmeridge is disappointed that PDC has chosen to respond to ISS's independent analysis of our position by issuing letters to shareholders that contain misinformation and baseless attacks. This rhetoric supports the view that change is needed at PDC. Specifically, in a May 20th Letter to PDC Shareholders, CEO Bart Brookman stated: "I also believe that Ben Dell, Kimmeridge's leader, is primarily focused on pushing PDC to engage in mergers with our competitors, including transactions in which he would be a financial participant. I believe that this, together with possible other economic interests he holds, present serious conflicts of interest." Kimmeridge highlighted it does not own shares in publicly traded energy companies other than PDC.
|
AIHS | Hot Stocks07:10 EDT Senmiao Technology announces cooperation agreement with Sichuan Feiniu - Senmiao Technology, an operator of an online lending marketplace for loan facilitation, and a provider of automobile transaction and financing services in China, announced that Sichuan Jinkailong Automobile Leasing, a variable interest entity of Senmiao's majority owned subsidiary, entered into a cooperation agreement with Sichuan Feiniu Automobile Transportation, a provider of intercity passenger transportation and freight logistics services, to jointly develop an intercity long-distance carpool business in the metropolitan area of Chengdu, Sichuan, China via the ridesharing platform of Didi Chuxing Technology, China's largest ridesharing platform, which offers a full range of app-based transportation options for 550M users.
|
ARGO | Hot Stocks07:10 EDT Voce withdraws Argo Group nominations, will review potential legal remedies - Voce Capital Management, the beneficial owner of approximately 5.6% of the shares of Argo Group, issued the following statement to its fellow shareholders in connection with the Company's upcoming 2019 Annual Meeting of Shareholders: "Earlier this year, Voce sought and obtained regulatory approval for its proxy solicitation at Argo from all relevant state Departments of Insuranc. Despite the fact that the solicitation of limited, narrow proxies in connection with an annual meeting of shareholders in an effort to elect fully-independent Director nominees in no way constitutes 'control' of Argo by Voce, we nonetheless cooperated with the state DOI procedures, responding to all inquiries posed and submitting extensive documentary information in support of our position. As a result, every state - Illinois, New York, Ohio, Pennsylvania and Virginia - granted approval for us to proceed prior to the filing of our definitive proxy statement on April 12, 2019. However, we have recently been advised by two states that they have now flip-flopped, at the 11th hour, revoking their prior approvals and casting doubt on our ability to proceed; Virginia became the second state to do so, in a letter dated yesterday. Argo's active role in lobbying the various DOI is clear and irrefutable. We believe that the officials reversed their previously well-founded positions as a result of Argo's misinformation. In fact, Virginia explicitly stated in its letter to us that it had 'considered additional materials and information provided by Argo' in rescinding its previous approval. Argo's actions are reprehensible..But most importantly, Argo's Board has now disenfranchised its shareholders by helping foment uncertainty as to whether votes cast against it at the Annual Meeting will even be counted. For example, the Illinois DOI has threatened to "pursue injunctive relief and/or to seek the voiding of any proxy votes cast," should our contest proceed. The implications of this should send a chill down the spine of not only Argo shareholders but owners of any insurance company and, frankly, anyone who cares about corporate governance. Given these disturbing, last-minute developments, it is clear there is a cloud of uncertainty hanging over the Annual Meeting and its potential outcome. Accordingly, we have no choice but to withdraw our nominations for election of directors at the Annual Meeting, and cease soliciting proxies therefor. In the meantime, we plan to register our dissatisfaction with the Company's outrageous actions by voting AGAINST the election of Argo's five Class III directors on the Company's WHITE proxy card. At this time, many of the Company's largest shareholders have yet to cast their votes, and we encourage them to follow our lead and withhold their votes on the Company's card...Moving forward, we are evaluating all potential legal remedies for this situation, including potentially requisitioning a Special General Meeting. We continue to believe in Argo's potential to deliver far greater value for its shareholders, and look forward to continuing our efforts to right the ship at Argo."
|
KSS | Hot Stocks07:08 EDT Kohl's down 10.4% after reporting Q1 results, FY19 adj. EPS guidance cut
|
VFF | Hot Stocks07:08 EDT Village Farms to form joint venture with Arkansas Valley Hemp - Village Farms International announced it has entered into an agreement with Arkansas Valley Hemp to form a joint venture for the outdoor cultivation of high-cannabidiol, or CBD, hemp and CBD extraction in Colorado. The joint venture, Arkansas Valley Green and Gold Hemp will be 60%-owned by Village Farms, 35%-owned by AV Hemp, and 5%-owned by Village Fields Hemp. Based in the Arkansas Valley of Colorado, AV Hemp was established by the founder of one of Colorado's largest licensed outdoor cannabis growing operations and real estate developer, specifically to capitalize on the significant opportunity in hemp-derived CBD.
|
JCP | Hot Stocks07:07 EDT J.C. Penney CEO says the company made good progress on immediate action steps - "I am pleased with the strides we've made in setting key objectives, building our senior leadership team, executing significant changes in our assortment, such as eliminating major appliances, and mobilizing the entire organization around our priorities. We have made good progress on each of our immediate action steps highlighted last quarter, including our continued efforts to reduce and enhance our inventory position, which resulted in a 16 % reduction in our inventory and a meaningful improvement in our free cash flow this quarter. As our inventory rationalization effort continues, we are testing a number of strategies around optimal inventory levels and assortment choice counts with a goal of delivering an improved experience for our customers and maximizing our return on investment," said Jill Soltau, CEO of JCPenney. "Retail is a dynamic business with many touchpoints that together lead back to the customer experience. We are working to reestablish the fundamentals of retail at JCPenney, and at the same time, we are building capabilities to satisfy the wants and expectations of our customers. In everything we do, we are putting the customer at the center. My commitment is that we will make sound, strategic decisions backed by data and will always be rooted in delivering on our customers' wants and expectations. Our current efforts are focused around two parallel paths. First, we are continuing to map out a comprehensive long-term strategy for JCPenney, which we look forward to sharing in the coming months. Second, we are working quickly to build a talented and accomplished team of retail experts. JCPenney is an American retail icon that is very important to all of our stakeholders, and I am encouraged by the early signs I am seeing in our business as we work to realize the potential that lies ahead," Soltau added.
|
AZO | Hot Stocks07:07 EDT AutoZone opened 35 new stores in the U.S in Q3 - During the quarter ended May 4, AutoZone opened 35 new stores in the U.S., eight stores in Mexico and three stores in Brazil. As of May 4, the company had 5,686 stores in 50 states in the U.S., the District of Columbia and Puerto Rico, 576 stores in Mexico, and 25 stores in Brazil for a total count of 6,287.
|
MNK | Hot Stocks07:06 EDT Mallinckrodt subsidiary files suit against U.S. HHS and CMS - Mallinckrodt confirmed its subsidiary, Mallinckrodt ARD, has filed suit in federal district court against the HHS and CMS. The action seeks to hold unlawful and set aside the Agency's recent unjustified decision to require that Mallinckrodt change the base date average manufacturer price used to calculate Medicaid drug rebates for Acthar Gel. The CMS decision attempts to reverse without explanation the Agency's 2012 express, written approval of the base date AMP used since 2013, prior to Mallinckrodt's acquisition of Acthar Gel. "We are disappointed with the action taken by CMS. With our repeated attempts to engage both HHS and CMS in productive discussions ultimately rebuffed, we find ourselves with no other choice than to vigorously defend our position, through the courts, that Medicaid patients should have access to this important therapy," said Mark Casey, General Counsel of Mallinckrodt. The effect of this attempted reversal, which CMS seeks unlawfully to make retroactive, would substantially eliminate Medicaid net sales of Acthar Gel, and significantly undermine Mallinckrodt's efforts to continue building on its investment in non-sales and marketing activities of more than $500M to modernize Acthar Gel - value demonstrated, in part, by positive clinical results for challenging-to-manage sub-populations including, for example, in rheumatoid arthritis. Importantly, the CMS decision risks the availability of the drug for some of America's poorest and most vulnerable patients. More broadly, if implemented, this CMS decision could impede Mallinckrodt's ability to continue its current pace of additional investment of hundreds of millions of dollars in research and development for a pipeline that seeks to benefit often very sick patient populations with some of the fewest treatment options available. The company's current research and development activities are focused on amyotrophic lateral sclerosis, Duchenne muscular dystrophy, Niemann-Pick disease type C, hepatorenal syndrome type-1 and severe burns, among others.
|
SESN FUJIY | Hot Stocks07:05 EDT Sesen Bio announces FDA acceptance of analytical comparability plan - Sesen Bio (SESN) announced that the company has completed its Type C CMC meeting and has reached agreement with the U.S. Food and Drug Administration on the Analytical Comparability Plan, and that, subject to final comparability data to be provided in the BLA submission, no additional clinical trials to establish comparability are deemed necessary at this time. In its Phase 2 and 3 clinical trials, Sesen Bio manufactured Vicinium in its facility in Winnipeg, Manitoba. Based on the company's assessment of the global demand potential for Vicinium, Sesen Bio sought a commercial manufacturer. In October 2018, Sesen Bio entered into an agreement for the manufacturing process and technology transfer of Vicinium production with FUJIFILM Diosynth Biotechnologies (FUJIY). In April 2019, the first in a series of full-scale, commercial GMP runs was successfully completed at FUJIFILM. The final bulk drug substance produced in this first run met all release specifications. On June 6, 2019, Sesen Bio will meet with the FDA for its second scheduled meeting, a Type B Pre-BLA meeting, to discuss the registration strategy for Vicinium. Due to the wide-range of topics to be discussed at the Pre-BLA meeting, the Company plans to provide an update on the outcome of that meeting upon receipt of the final meeting minutes, which is typically within 30 days.
|
TBPH | Hot Stocks07:04 EDT Theravance Biopharma reports data from Phase 1b study of JAK inhibitor TD-1473 - Theravance Biopharma reported data from the exploratory Phase 1b study of the gut-selective pan-Janus kinase, or JAK, inhibitor, TD-1473, in an oral presentation at Digestive Disease Week, or DDW. Presented data demonstrated that four weeks of TD-1473 treatment produced signals of clinical, histologic, and biomarker activity, suggesting the achievement of localized target engagement in patients with moderately-to-severely active ulcerative colitis, or UC. Additionally, in this study, data demonstrated minimal systemic exposures and suggested no evidence of systemic immunosuppression or systemic opportunistic infections associated with the gut-selective compound. This localization of biological activity within the target organ highlights potential differentiation for TD-1473 as compared to systemically active JAK inhibitors on the market or in development, which have been associated with dose-limiting toxicity. DDW 2019 is being held May 18-21 in San Diego, CA.
|
BR | Hot Stocks07:03 EDT Broadridge enters into $300M purchase agreement to acquire RPM technologies - Broadridge Financial Solutions announced that it has entered into a purchase agreement to acquire RPM Technologies, a leading Canadian provider of enterprise wealth management software solutions and services for approximately $300M. RPM's technology platforms support over 15 million customer accounts. The transaction is expected to contribute $40M-50M in revenues to Broadridge in FY20 and is not expected to have a material impact on Broadridge's Adjusted EPS. Broadridge is purchasing RPM from its current owners which include Bayshore Capital. The closing of the transaction is subject to the completion of an intercompany reorganization by RPM Technologies and standard customary closing conditions. RBC Capital Markets is acting as exclusive financial advisor to Broadridge. Canaccord Genuity is acting as exclusive financial advisor to RPM.
|
AZO | Hot Stocks07:01 EDT AutoZone reports inventory up 8.0% y/y - The company's inventory increased 8.0% over the same period last year, driven by new stores and increased product placement.
|
ZOM | Hot Stocks06:57 EDT Zomedica announces TRUFORMA achieves two milestones - Zomedica Pharmaceuticals announced that TRUFORMA, its point-of-care biosensor platform, recently achieved two important product development milestones. The TRUFORMA platform, formerly designated ZM-024, is a table-top instrument that will use disposable assay cartridges to test a range of samples including whole blood, serum, and plasma. The platform uses differentiated Bulk Acoustic Wave, or BAW, sensor technology to provide a non-optical and fluorescence-free detection system for use at the point-of-care. The milestones achieved are beta finalization of the instrument design and the completion of feasibility testing of the TRUFORMA platform's first assays. Completion of the beta design milestone allows a transition to commercial production for the instrument.
|
MRK | Hot Stocks06:49 EDT Merck to acquire Peloton Therapeutics for $1.05B in cash - Merck and Peloton Therapeutics announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire privately held Peloton, a clinical-stage biopharmaceutical company focused on the development of novel small molecule therapeutic candidates targeting hypoxia-inducible factor-2alpha for the treatment of patients with cancer and other non-oncology diseases. Peloton's lead candidate is PT2977, an oral HIF-2alpha inhibitor in late-stage development for renal cell carcinoma, or RCC. Under terms of the agreement, Merck will acquire all outstanding shares of Peloton in exchange for an upfront payment of $1.05B in cash. In addition, Peloton shareholders will be eligible to receive a further $1.15B contingent upon successful achievement of future regulatory and sales milestones for certain candidates. PT2977 is a potent, selective, investigational oral HIF-2alpha inhibitor currently being evaluated in multiple clinical studies. Specifically, PT2977 is being evaluated in a Phase 2 clinical trial in von Hippel-Lindau disease-associated RCC, a Phase 2 clinical trial in combination with cabozantinib, a VEGFR-targeting agent, in metastatic RCC, a Phase 1/2 dose-escalation and dose-expansion clinical trial in patients with metastatic RCC, and an expansion arm of its Phase 1/2 clinical trial in glioblastoma multiforme.
|
SON | Hot Stocks06:48 EDT Sonoco announces contributions of $200M to U.S. Defined Benefit Pension Plans - Sonoco announced it is making voluntary contributions of approximately $200M to its U.S. Defined Benefit Pension Plans. According to Julie Albrecht, Sonoco's Vice President and CFO, the voluntary contributions are projected to increase the funded status of the Company's U.S. Defined Benefit Plans to approximately 100%. Sonoco previously closed its U.S. defined retirement plans at the end of 2003 and ceased additional benefit accruals at year-end 2018 involving all employees in the final average pay pension formula within these pension plans. To fund the voluntary contributions to the pension plans, Sonoco has entered into a $200M, one-year term loan with a relationship bank. The pre-payable, unsecured loan has an option to renew for a second year and has an interest rate of LIBOR plus 1.0%, based on the Company's current investment grade credit rating.
|
CR CIR | Hot Stocks06:35 EDT Crane proposes to acquire Circor for $45.00 per share in cash - Crane Co. (CR) announced that it has submitted a proposal to the Board of Directors of CIRCOR International (CIR) to acquire CIRCOR for $45 per share in cash. The proposal represents a 47% premium over yesterday's closing price and a 37% and 51% premium over a three- and six-month volume weighted average share price, respectively. This reflects an enterprise value of approximately $1.7B at a multiple of approximately 13.5x the last 12-month adjusted EBITDA. Crane Co. proposed the all-cash transaction to CIRCOR's President and CEO Scott Buckhout on April 30, the terms of which were confirmed by a letter to the CIRCOR Board of Directors. On May 13, the CIRCOR Board summarily rejected Crane Co.'s proposal with no offer of discussions or due diligence. "While we had hoped to complete a transaction privately, the Board's rejection of our proposal without comment or discussion led to our decision to make our proposal known to CIRCOR shareholders so they can express their views directly to the CIRCOR Board," said Max Mitchell, Crane Co. President and CEO. "Our proposal provides CIRCOR shareholders with attractive value and certainty compared to the continued uncertainty surrounding CIRCOR's plans to improve operating performance. Based on CIRCOR's history of underperformance and inability to meet its own financial targets, we believe CIRCOR's standalone plan is unlikely to generate value comparable to what we are proposing." Mitchell continued, "We believe that this business, which has great brands and products, has been meaningfully undermanaged for years. This has resulted in a persistent decline in CIRCOR's share price, making it the worst performer of the peers in the S&P Midcap Capital Goods Index since the end of 2013. Based upon the strength of our disciplined operating approach, Crane Co. is well positioned to integrate CIRCOR's businesses into our focused portfolio, realize operational synergies, and deliver long-term value to Crane shareholders. Combining CIRCOR's Fluid Handling, Aerospace and Defense assets with Crane's portfolio of leading brands would create a stronger competitor with additional scale and growth potential."
|
AJG | Hot Stocks06:33 EDT Arthur J. Gallagher purchases minority stake in EIBL - Arthur J. Gallagher announced that it has purchased a minority stake in Edelweiss Insurance Brokers Limited, or EIBL, a wholly owned subsidiary of Edelweiss Group, India's diversified financial services conglomerate. The deal is subject to approval by the Insurance Regulatory and Development Authority of India. Headquartered in Mumbai, with branches in Dehli, Kolkata and Bangalore, EIBL is a corporate insurance broker offering general insurance solutions to institutional as well as individual clients across India. India's growing commercial and specialty market is supported by demand for specialist coverages such as renewable energy, infrastructure and cyber liability.
|
CR | Hot Stocks06:33 EDT Crane proposes to acquire Circor for $45.00 per share in cash - Crane Co. (CR) announced that it has submitted a proposal to the Board of Directors of CIRCOR International (CIR) to acquire CIRCOR for $45 per share in cash. The proposal represents a 47% premium over yesterday's closing price and a 37% and 51% premium over a three- and six-month volume weighted average share price, respectively. This reflects an enterprise value of approximately $1.7B at a multiple of approximately 13.5x the last 12-month adjusted EBITDA. Crane Co. proposed the all-cash transaction to CIRCOR's President and CEO Scott Buckhout on April 30, the terms of which were confirmed by a letter to the CIRCOR Board of Directors. On May 13, the CIRCOR Board summarily rejected Crane Co.'s proposal with no offer of discussions or due diligence. "While we had hoped to complete a transaction privately, the Board's rejection of our proposal without comment or discussion led to our decision to make our proposal known to CIRCOR shareholders so they can express their views directly to the CIRCOR Board," said Max Mitchell, Crane Co. President and CEO. "Our proposal provides CIRCOR shareholders with attractive value and certainty compared to the continued uncertainty surrounding CIRCOR's plans to improve operating performance. Based on CIRCOR's history of underperformance and inability to meet its own financial targets, we believe CIRCOR's standalone plan is unlikely to generate value comparable to what we are proposing." Mitchell continued, "We believe that this business, which has great brands and products, has been meaningfully undermanaged for years. This has resulted in a persistent decline in CIRCOR's share price, making it the worst performer of the peers in the S&P Midcap Capital Goods Index since the end of 2013. Based upon the strength of our disciplined operating approach, Crane Co. is well positioned to integrate CIRCOR's businesses into our focused portfolio, realize operational synergies, and deliver long-term value to Crane shareholders. Combining CIRCOR's Fluid Handling, Aerospace and Defense assets with Crane's portfolio of leading brands would create a stronger competitor with additional scale and growth potential."
|
VRNT | Hot Stocks06:33 EDT Verint sets 3-year targets, sees Customer Engagement revenue about $1.1B - In investor presentation slides, Verint provided three year targets for Customer Engagement, including revenue of about $1.1B, a 10% CAGR. The company also sees Cloud as greater than 40% of total revenue, Recurring about 70% of total revenue, as well as about 30% adjusted EBITDA margins, gross margin expansion and opex leverage. For Maintenance, Verint sees revenue flat to modestly down over the next three years.
|
CR CIR | Hot Stocks06:30 EDT Crane proposes to acquire Circor for $45.00 per share in cash
|
MSFT | Hot Stocks06:24 EDT Xbox chief Phil Spencer outlines plans for fighting toxicity in gaming - The head of Xbox wrote a blog spelling out how the company plans to combat toxicity in gaming. Phil Spencer in a blog post titled "Video Games: A Unifying Force for the World" that Microsoft is committing itself to new initiatives aimed at making gaming widely more accessible and safer, starting by expanding its safety team. Spencer said: "First, gaming is for everyone. No one group 'owns'" gaming. Instead, whether you're new to gaming or are a diehard e-sports fan, you are welcome to play and welcome to all the fun and skill-building that comes with gaming. In this way, when everyone can play, the entire world wins." Spencer says he believes in what he calls two fundamental truths for gaming: that the medium is for everyone no matter your age, gender, nationality, orientation, or skin color. The other is that, for gaming's benefits to be accessible to all people in the world, companies like Microsoft and others need to foster a safe gaming culture and online environment, both through policies and tools and through positive changes to the community and industry itself. "Gaming must be a safe environment. Creating community is shared work, and protecting community is essential work, so, we all carry part of the payload of community safety - game industry and gamers alike." He added: "By uniting as an industry, we can thoughtfully and deliberately continue building a safe and inclusive gaming environment for everyone. Microsoft, Team Xbox, and I are personally committing to this, beginning with the following principles and actions: We commit to be vigilant, proactive, and swift. We commit to empowering you to safeguard your gaming experience the way you want. We commit to working across the gaming industry on safety measures." Reference Link
|
CAAP | Hot Stocks06:05 EDT Corporacion America Airport reports Q1 passenger traffic up 4.0% YoY to 20.4M - Reports Q1 cargo volume up 6.3% to 104.8 thousand tons, and aircraft movements declined 0.3% to 212,700.
|
HD | Hot Stocks06:04 EDT Home Depot reports Q1 U.S. SSS up 3% - "We were pleased with the underlying performance of the core business despite unfavorable weather in February and significant deflation in lumber prices compared to a year ago," said Craig Menear, chairman, CEO and president. "Looking ahead, we remain excited about the momentum we are seeing with our strategic investments. As a result of these initiatives, and the current macroeconomic and housing backdrop, today we are reaffirming our sales and earnings guidance for fiscal 2019. I would like to thank our associates for their hard work and continued dedication to our customers."
|
FB | Hot Stocks05:57 EDT Facebook says Oculus Quest and Oculus Rift S are now shipping globally - Facebook's Oculus Quest and Rift S are now shipping globally, the company said in a blog post. It added: "With all-in-one, fully immersive 6DOF VR, we're bringing the magic of presence to more people than ever before-and we're doing it with the freedom of fully untethered movement. Our commitment to PC-powered VR gaming continues, with incredible titles like Asgard's Wrath, Defector, and Stormland on the horizon. Combined, the addition of Quest and Rift S to our hardware portfolio will help developers usher in the next level of VR gaming. We've been blown away by the community's response since we opened pre-orders for Quest and Rift S at F8, and we're excited for your patience and dedication to pay off in a big way." Reference Link
|
NVLN | Hot Stocks05:26 EDT Novelion announces Aegerion to recapitalize through court supervised process - Novelion Therapeutics announced that its wholly-owned subsidiary Aegerion Pharmaceuticals has entered into a plan funding agreement, or PFA, and a restructuring support agreement (RSA) that will result in Aegerion selling 100% of its reorganized stock to, and becoming a wholly-owned subsidiary of, Dublin-based Amryt Pharma. The agreements, which will result in a recapitalization of Aegerion, are the result of the previously announced capital structure and strategic review undertaken independently by the boards of Novelion and Aegerion, and a broad marketing process. The Recapitalization of Aegerion pursuant to the PFA and a proposed Chapter 11 plan of reorganization has been approved by Aegerion's board and approved and recommended by the independent restructuring committee of Aegerion's board. Novelion's board has approved Novelion's entry into the RSA and support for Aegerion's proposed Chapter 11 restructuring. In conjunction with the Recapitalization, Aegerion has entered into the RSA with many of its key stakeholders, including Novelion, the holders of in excess of 67% of the 2.00% convertible notes issued by Aegerion due 2019 and the holders of 100% of the principal amount under Aegerion's other indebtedness for borrowed money. To facilitate the Recapitalization, Aegerion and its U.S. subsidiary Aegerion Pharmaceuticals Holdings have commenced cases in the United States Bankruptcy Court for the Southern District of New York pursuant to Chapter 11 of the United States Code. Aegerion will continue to operate in the ordinary course of business during the Chapter 11 process. The non-U.S. subsidiaries of Aegerion are not part of the Chapter 11 proceedings. The Recapitalization ascribes an enterprise value to Aegerion and Amryt of $395 million and $146 million, respectively, excluding cash and cash equivalents and subject to adjustment for accrued interest and certain payments that are due to the DOJ and the SEC. The key terms of the Recapitalization, which are subject to Bankruptcy Court approval and other customary conditions.
|
CLX | Hot Stocks05:03 EDT Clorox raises quarterly dividend to $1.06 per share from 96c per share - Clorox announced that its board has declared a 10% increase in the quarterly dividend, from 96c to $1.06 per share on the company's common stock. The dividend is payable August 16, to stockholders of record as of the close of business on July 31.
|